Lars Egevad

Article: EUROPEAN UROLOGY ONCOLOGY. 2025;8(1):80-86

Effectiveness and Cost-effectiveness of Artificial Intelligence-assisted Pathology for Prostate Cancer Diagnosis in Sweden: A Microsimulation Study

Du X; Hao S; Olsson H; Kartasalo K; Mulliqi N; Rai B; Menges D; Heintz E; Egevad L; Eklund M; Clements M

Article: MODERN PATHOLOGY. 2025;38(5):100715

Physical Color Calibration of Digital Pathology Scanners for Robust Artificial Intelligence-Assisted Cancer Diagnosis

Ji X; Salmon R; Mulliqi N; Khan U; Wang Y; Blilie A; Olsson H; Pedersen BG; Sorensen KD; Ulhoi BP; Kjosavik SR; Janssen EAM; Rantalainen M; Egevad L; Ruusuvuori P; Eklund M; Kartasalo K

Article: NEW ENGLAND JOURNAL OF MEDICINE. 2024;391(12):1083-1095

Results after Four Years of Screening for Prostate Cancer with PSA and MRI

Hugosson J; Godtman RA; Wallstrom J; Axcrona U; Bergh A; Egevad L; Geterud K; Khatami A; Socratous A; Spyratou V; Svensson L; Stranne J; Mansson M; Hellstrom M

Article: BJUI COMPASS. 2024;5(9):999-1006

Long-term oncological outcomes after multimodal treatment for locally advanced prostate cancer

Roldan FL; Falagario UG; Olsson M; Salas RS; Aly M; Egevad L; Lantz A; Gronberg H; Akre O; Hosseini A; Wiklund NP

Article: EUROPEAN UROLOGY ONCOLOGY. 2024;7(4):888-896

Assessing the Impact of Positive Surgical Margins on Mortality in Patients Who Underwent Robotic Radical Prostatectomy: 20 Years Report from the EAU Robotic Urology Section Scientific Working Group '

Pellegrino F; Falagario UG; Knipper S; Martini A; Akre O; Egevad L; Aly M; Moschovas MC; Bravi CA; Tran J; Heiniger Y; von Kempis A; Schaffar R; Carrieri G; Briganti A; Montorsi F; Rochat C-H; Mottrie A; Ahlering TE; John H; Patel V; Graefen M; Wiklund P

Article: EUROPEAN UROLOGY ONCOLOGY. 2024;7(4):705-712

Prostate Cancer-specific and All-cause Mortality After Robot-assisted Radical Prostatectomy: 20 Years' Report from the European Association of Urology Robotic Urology Section Scientific Working Group

Falagario UG; Knipper S; Pellegrino F; Martini A; Akre O; Egevad L; Groenberg H; Moschovas MC; Bravi CA; Tran J; Heiniger Y; von Kempis A; Schaffar R; Carrieri G; Rochat C-H; Mottrie A; Ahlering TE; John H; Patel V; Graefen M; Wiklund P

Article: VIRCHOWS ARCHIV. 2024;484(6):995-1003

Prognosis of Gleason score 8 prostatic adenocarcinoma in needle biopsies: a nationwide population-based study

Egevad L; Micoli C; Delahunt B; Samaratunga H; Orrason AW; Garmo H; Stattin P; Eklund M

Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2024;59:76-83

Temporal trend in risk of prostate cancer death in men with favourable-risk prostate cancer

Thomsen FF; Garmo H; Egevad L; Stattin P; Brasso K

Article: EUROPEAN UROLOGY ONCOLOGY. 2024;7(2):213-221

Prognosis of Gleason Score 9-10 Prostatic Adenocarcinoma in Needle Biopsies: A Nationwide Population-based Study

Egevad L; Micoli C; Samaratunga H; Delahunt B; Garmo H; Stattin P; Eklund M

Journal article: JOURNAL OF CLINICAL PATHOLOGY. 2024;77(3):164-168

Macroscopic examination of pathology specimens: a critical reappraisal

Varma M; Collins LC; Chetty R; Karamchandani DM; Talia K; Dormer J; Vyas M; Conn B; Guzman-Arocho YD; Jones AV; Pring M; Mccluggage WG

Article: PATHOLOGY. 2024;56(1):33-38

Gleason score 3+3[6 prostatic adenocarcinoma is not benign and the current debate is unhelpful to clinicians and patients

Samaratunga H; Egevad L; Yaxley J; Perry-Keene J; Le Fevre I; Kench J; Matsika A; Bostwick D; Iczkowski K; Delahunt B

Journal article: PATHOLOGY. 2024;56(1):138-141

Myxoid pleomorphic liposarcoma of the orbit: intratumoural genetic similarities and heterogeneity

Tan GZL; Yong MH; Tiu LA; Dolendo M; Mok Y

Journal article: PATHOLOGY. 2024;56(1):138-141

Myxoid pleomorphic liposarcoma of the orbit: intratumoural genetic similarities and heterogeneity

Tan GZL; Yong MH; Tiu LA; Dolendo M; Mok Y

Article: JOURNAL OF CLINICAL PATHOLOGY. 2023;77(1):22-26

Use of the ISUP e-learning module improves interrater reliability in prostate cancer grading

Flach RN; Egevad L; Eklund M; van der Kwast TH; Delahunt B; Samaratunga H; Suelmann BBM; Willemse P-PM; Meijer RP; van Diest PJ

Article: UROLOGY. 2023;181:84-91

Surveillance for Nonmuscle Invasive Bladder Cancer: Identifying the Point of Diminishing Returns

Ranti D; Dey L; Bieber C; Grauer R; Rich J; Rosenzweig S; Koskela LR; Steineck G; Hosseini A; Egevad L; Patrakka J; Attalla K; Wiklund P; Sfakianos J; Waingankar N

Article: APMIS. 2023;131(10):528-535

Web-grading-a tool to test personal grading of renal and prostate cancer.

Kristiansen G; Schmid M; Egevad L; Samaratunga H; Varma M; Inam K; Thiesen H-J; Delahunt B; Dai Y

Article: CELLS. 2023;12(17):2158

Deciphering the Role of p60AmotL2 in Epithelial Extrusion and Cell Detachment

Cui W; Subramani A; Fonseca P; Zhang Y; Tong L; Zhang Y; Egevad L; Lundqvist A; Holmgren L

Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2023;47(6):701-708

Clinicopathologic Significance of Anterior Prostate Cancer Comparison With Posterior Prostate Cancer in the Era of Multiparametric Magnetic Resonance Imaging

Samaratunga H; Egevad L; Yaxley JWW; Johannsen S; Le Fevre IKK; Perry-Keene JLL; Gianduzzo T; Chabert C; Coughlin G; Parkinson R; Kua B; Yaxley W; Delahunt B

Article: HISTOPATHOLOGY. 2023;82(6):837-845

Interobserver reproducibility of cribriform cancer in prostate needle biopsies and validation of International Society of Urological Pathology criteria

Egevad L; Delahunt B; Iczkowski KA; van der Kwast T; van Leenders GJLH; Leite KRM; Pan C-C; Samaratunga H; Tsuzuki T; Mulliqi N; Ji X; Olsson H; Valkonen M; Ruusuvuori P; Eklund M; Kartasalo K

Article: CLINICAL CANCER RESEARCH. 2023;29(7):1220-1231

Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma

Vasudev NS; Scelo G; Glennon KI; Wilson M; Letourneau L; Eveleigh R; Nourbehesht N; Arseneault M; Paccard A; Egevad L; Viksna J; Celms E; Jackson SM; Abedi-Ardekani B; Warren AY; Selby PJ; Trainor S; Kimuli M; Cartledge J; Soomro N; Adeyoju A; Patel PM; Wozniak MB; Holcatova I; Brisuda A; Janout V; Chanudet E; Zaridze D; Moukeria A; Shangina O; Foretova L; Navratilova M; Mates D; Jinga V; Bogdanovic L; Kovacevic B; Cambon-Thomsen A; Bourque G; Brazma A; Tost J; Brennan P; Lathrop M; Riazalhosseini Y; Banks REAll authors

Article: EBIOMEDICINE. 2023;88:104427

Computational pathology in 2030: a Delphi study forecasting the role of AI in pathology within the next decade

Berbis MA; McClintock DS; Bychkov A; Van der Laak J; Pantanowitz L; Lennerz JK; Cheng JY; Delahunt B; Egevad L; Eloy C; Farris III AB; Fraggetta F; del Moral RG; Hartman DJ; Herrmann MD; Hollemans E; Iczkowski KA; Karsan A; Kriegsmann M; Salama ME; Sinard JH; Tuthill JM; Williams B; Casado-Sanchez C; Sanchez-Turrion V; Luna A; Aneiros-Fernandez J; Shen J

Article: NATURE COMMUNICATIONS. 2022;13(1):7761

Estimating diagnostic uncertainty in artificial intelligence assisted pathology using conformal prediction

Olsson H; Kartasalo K; Mulliqi N; Capuccini M; Ruusuvuori P; Samaratunga H; Delahunt B; Lindskog C; Janssen EAM; Blilie A; Egevad L; Spjuth O; Eklund M

Article: NEW ENGLAND JOURNAL OF MEDICINE. 2022;387(23):2126-2137

Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only

Hugosson J; Mansson M; Wallstrom J; Axcrona U; Carlsson SV; Egevad L; Geterud K; Khatami A; Kohestani K; Pihl C-G; Socratous A; Stranne J; Godtman RA; Hellstrom M

Article: PATHOLOGY. 2022;54(7):842-847

LOT and HOT ... or not. The proliferation of clinically insignificant and poorly characterised types of renal neoplasia

Samaratunga H; Egevad L; Thunders M; Iczskowski KA; van der Kwast T; Kristiansen G; Pan C-C; Leite KRM; Evans A; Clouston D; Kenwright DN; Bethwaite PB; Malone G; Wood S; Yaxley JW; Delahunt B

Article: BJU INTERNATIONAL. 2022;130(Suppl 3):40-45

Oncological and urinary outcomes following low-dose-rate brachytherapy with a median follow-up of 11.8 years

Yaxley WJ; Mackean J; Desai DJ; Tsang G; Dixon J; Samaratunga H; Delahunt B; Egevad L; Gardiner RA; Yaxley JW

Article: EUROPEAN UROLOGY OPEN SCIENCE. 2022;44:69-75

Digital Rectal Examination in Stockholm3 Biomarker-based Prostate Cancer Screening

Andersson J; Palsdottir T; Lantz A; Aly M; Gronberg H; Egevad L; Eklund M; Nordstrom T

Article: PATHOLOGY. 2022;54(6):694-699

Prognostic significance of percentage Gleason grade 5 prostatic adenocarcinoma in needle biopsies from patients treated by radical prostatectomy

Yaxley W; Delahunt B; Yaxley J; Thundeer MC; Kenwright DN; Egevad L; Samaratunga H

Article: ISCIENCE. 2022;25(7):104663

Using deep learning to detect patients at risk for prostate cancer despite benign biopsies

Liu B; Wang Y; Weitz P; Lindberg J; Hartman J; Wang W; Egevad L; Gronberg H; Eklund M; Rantalainen M

Article: EUROPEAN UROLOGY OPEN SCIENCE. 2022;41:1-7

External Validation of the Prostate Biopsy Collaborative Group Risk Calculator and the Rotterdam Prostate Cancer Risk Calculator in a Swedish Population-based Screening Cohort

Engel JC; Palsdottir T; Ankerst D; Remmers S; Mortezavi A; Chellappa V; Egevad L; Gronberg H; Eklund M; Nordstrom T

Article: VIRCHOWS ARCHIV. 2022;481(1):73-82

Detection of perineural invasion in prostate needle biopsies with deep neural networks

Kartasalo K; Strom P; Ruusuvuori P; Samaratunga H; Delahunt B; Tsuzuki T; Eklund M; Egevad L

Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2022;49(9):3289-3294

Primary tumour PSMA intensity is an independent prognostic biomarker for biochemical recurrence-free survival following radical prostatectomy

Roberts MJ; Morton A; Papa N; Franklin A; Raveenthiran S; Yaxley WJ; Coughlin G; Gianduzzo T; Kua B; McEwan L; Wong D; Delahunt B; Egevad L; Samaratunga H; Brown N; Parkinson R; Emmett L; Yaxley JW

Article: BIOINFORMATICS. 2022;38(13):3462-3469

Transcriptome-wide prediction of prostate cancer gene expression from histopathology images using co-expression-based convolutional neural networks

Weitz P; Wang Y; Kartasalo K; Egevad L; Lindberg J; Gronberg H; Eklund M; Rantalainen M

Article: VACCINE. 2022;40(27):3797-3801

Travel vaccines are strongly associated to reduced mortality in prostate cancer patients-a real effect or residual confounding?

Moeller A; Schwamborn K; Spillmann A; Hoogstraate J; Szulkin R; Akre O; Egevad L; Clements M; Aly M

Article: PROSTATE. 2022;82(5):576-583

Ductal and acinar components of mixed prostatic adenocarcinoma frequently have a common clonal origin

Lindh C; Samaratunga H; Delahunt B; Bergstrom R; Chellappa V; Yaxley J; Lindberg J; Egevad L

Article: JOURNAL OF UROLOGY. 2022;207(3):573-580

Findings in 1,123 Men with Preoperative ⁶⁸Ga-Prostate-Specific Membrane Antigen Positron Emission Tomography/Computerized Tomography and Multiparametric Magnetic Resonance Imaging Compared to Totally Embedded Radical Prostatectomy Histopathology: Implications for the Diagnosis and Management of Prostate Cancer

Raveenthiran S; Yaxley WJ; Franklin T; Coughlin G; Roberts M; Gianduzzo T; Kua B; Samaratunga H; Delahunt B; Egevad L; Wong D; McEwan L; Brown N; Parkinson R; Esler R; Yaxley JW

Article: PATHOLOGY. 2022;54(1):49-54

Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: 10-year data from the TROG 03.04 RADAR trial

Delahunt B; Steigler A; Atkinson C; Christie D; Duchesne G; Egevad L; Joseph D; Kenwright DN; Matthews J; Murray JD; Oldmeadow C; Samaratunga H; Spry NA; Thunders MC; Hondermarck H; Denham JW

Article: NATURE MEDICINE. 2022;28(1):154-163

Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge

Bulten W; Kartasalo K; Chen P-HC; Strom P; Pinckaers H; Nagpal K; Cai Y; Steiner DF; van Boven H; Vink R; Hulsbergen-van de Kaa C; van der Laak J; Amin MB; Evans AJ; van der Kwast T; Allan R; Humphrey PA; Gronberg H; Samaratunga H; Delahunt B; Tsuzuki T; Hakkinen T; Egevad L; Demkin M; Dane S; Tan F; Valkonen M; Corrado GS; Peng L; Mermel CH; Ruusuvuori P; Litjens G; Eklund M

Article: BIOINFORMATICS. 2021;37(21):3995-3997

OpenPhi: an interface to access Philips iSyntax whole slide images for computational pathology

Mulliqi N; Kartasalo K; Olsson H; Ji X; Egevad L; Eklund M; Ruusuvuori P

Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2021;45(11):1527-1533

Intraductal Carcinoma of the Prostate Extreme Nuclear Size Is Not a Diagnostic Parameter

Samaratunga H; Delahunt B; Yaxley JW; Johannsen S; Egevad L

Article: EXPERIMENTAL AND MOLECULAR PATHOLOGY. 2021;122:104667

Nuclear and stromal expression of Manic fringe in renal cell carcinoma

Cheng WK; Kaur G; Sjoberg E; Frodin M; Egevad L; Harmenberg U; Li J-L; Oon CE

Article: JOURNAL OF SURGICAL ONCOLOGY. 2021;124(5):867-875

Temporal changes in cause-specific death in men with localised prostate cancer treated with radical prostatectomy: a population-based, nationwide study

Thomsen FB; Garmo H; Brasso K; Egevad L; Stattin P

Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2021;45(8):1118-1126

ISUP Consensus Definition of Cribriform Pattern Prostate Cancer

van der Kwast TH; van Leenders GJ; Berney DM; Delahunt B; Evans AJ; Iczkowski KA; McKenney JK; Ro JY; Samaratunga H; Srigley JR; Tsuzuki T; Varma M; Wheeler TM; Egevad L

Article: HEAD AND NECK PATHOLOGY. 2021;15(2):628-637

Perithyroidal Salivary Gland Acinic Cell Carcinoma: Morphological and Molecular Attributes of a Unique Lesion

Juhlin CC; Asa SL; Jatta K; Rodsari HN; Shabo I; Haglund F; Delahunt B; Samaratunga H; Egevad L; Hoog A; Zedenius J

Article: ANNALS OF DIAGNOSTIC PATHOLOGY. 2021;52:151733

Cribriform prostate cancer: Morphologic criteria enabling a diagnosis, based on survey of experts

Iczkowski KA; van Leenders GJLH; Tarima S; Wu R; Van der Kwast T; Berney DM; Evans AJ; Wheeler TM; Ro JY; Samaratunga H; Delahunt B; Srigley J; Varma M; Tsuzuki T; Egevad L

Article: VIRCHOWS ARCHIV. 2021;478(6):1109-1116

Interobserver reproducibility of perineural invasion of prostatic adenocarcinoma in needle biopsies

Egevad L; Delahunt B; Samaratunga H; Tsuzuki T; Olsson H; Strom P; Lindskog C; Hakkinen T; Kartasalo K; Eklund M; Ruusuvuori P

Article: PROSTATE CANCER AND PROSTATIC DISEASES. 2021;24(2):398-405

Histological findings of totally embedded robot assisted laparoscopic radical prostatectomy (RALP) specimens in 1197 men with a negative (low risk) preoperative multiparametric magnetic resonance imaging (mpMRI) prostate lobe and clinical implications

Yaxley WJ; Nouhaud F-X; Raveenthiran S; Franklin A; Donato P; Coughlin G; Kua B; Gianduzzo T; Wong D; Parkinson R; Brown N; Samaratunga H; Delahunt B; Egevad L; Roberts M; Yaxley JW

Article: VIRCHOWS ARCHIV. 2021;478(6):1099-1107

Morphological findings in frozen non-neoplastic kidney tissues of patients with kidney cancer from large-scale multicentric studies on renal cancer

Abedi-Ardekani B; Nasrollahzadeh D; Egevad L; Banks RE; Vasudev N; Holcatova I; Povysil C; Foretova L; Janout V; Mates D; Jinga V; Petrescu A; Milosavljevic S; Ognjanovic M; Ognjanovic S; Viksna J; Warren AY; Lathrop M; Riazalhosseini Y; Carreira C; Chanudet E; McKay J; Brennan P; Scelo G

Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2021;113(5):632-640

Incorporating Magnetic Resonance Imaging and Biomarkers in Active Surveillance Protocols - Results From the Prospective Stockholm3 Active Surveillance Trial (STHLM3AS)

Olsson H; Nordstrom T; Jaderling F; Egevad L; Vigneswaran HT; Annerstedt M; Gronberg H; Eklund M; Lantz A

Article: PATHOLOGE. 2021;42(3):310-318

Molecular pathology of urogenital tumors Recommendations from the 2019 International Society of Urological Pathology (ISUP) Consensus Conference

Hommerding O; Allory Y; Argani P; Bismar TA; Bubendorf L; Canete-Portillo S; Chaux A; Chen Y-B; Cheng L; Cubilla AL; Egevad L; Gill AJ; Grignon DJ; Hartmann A; Hes O; Idrees MT; Kao C-S; Knowles MA; Looijenge LHJ; Lota TLN; Pritchard CC; Rubin MA; Fins SAT; Van der Kwast TH; Velazquez EF; Warrick JI; Williamson SR; Kristiansen G

Article: APMIS. 2021;129(4):204-212

Prognostic role of TSPAN1, KIAA1324 and ESRP1 in prostate cancer

Stinnesbeck M; Kristiansen A; Ellinger J; Hauser S; Egevad L; Tolkach Y; Kristiansen G

Article: MODERN PATHOLOGY. 2021;34(3):660-671

Artificial intelligence assistance significantly improves Gleason grading of prostate biopsies by pathologists

Bulten W; Balkenhol M; Belinga J-JA; Brilhante A; Cakir A; Egevad L; Eklund M; Farre X; Geronatsiou K; Molinie V; Pereira G; Roy P; Saile G; Salles P; Schaafsma E; Tschui J; Vos A-M; van Boven H; Vink R; van der Laak J; Hulsbergen-van der Kaa C; Litjens G

Article: EUROPEAN UROLOGY OPEN SCIENCE. 2021;24:11-16

Identifying Prostate Cancer Among Men with Lower Urinary Tract Symptoms

Nordstrom T; Engel JC; Bergman M; Egevad L; Aly M; Eklund M; Palsdottir T; Gronberg H

Article: PATHOLOGY. 2021;53(2):199-204

Prognostic significance of morphological patterns of Gleason grade 5 prostatic adenocarcinoma diagnosed on needle biopsy

Franklin A; Delahunt B; Egevad L; Yaxley J; Johannsen S; Gianduzzo T; Ganter J; Pecoraro C; Thunders M; Samaratunga H

Article: PLOS ONE. 2021;16(2):e0246674

The cost-effectiveness of prostate cancer screening using the Stockholm3 test

Karlsson AA; Hao S; Jauhiainen A; Elfstrom KM; Egevad L; Nordstrom T; Heintz E; Clements MS

Article: PATHOLOGY. 2021;53(1):44-55

Tumour-like lesions of the urinary bladder

Samaratunga H; Delahunt B; Yaxley J; Egevad L

Article: PATHOLOGY. 2021;53(1):26-35

Benign mimics of prostate cancer

Egevad L; Delahunt B; Furusato B; Tsuzuki T; Yaxley J; Samaratunga H

Article: BJU INTERNATIONAL. 2021;127(1):71-79

Histological comparison between predictive value of preoperative 3-T multiparametric MRI and⁶⁸Ga-PSMA PET/CT scan for pathological outcomes at radical prostatectomy and pelvic lymph node dissection for prostate cancer

Franklin A; Yaxley WJ; Raveenthiran S; Coughlin G; Gianduzzo T; Kua B; McEwan L; Wong D; Delahunt B; Egevad L; Samaratunga H; Brown N; Parkinson R; Roberts MJ; Yaxley JW

Article: PATHOLOGY. 2021;53(1):120-128

Staging of renal cell carcinoma: current progress and potential advances

Delahunt B; Eble JN; Samaratunga H; Thunders M; Yaxley JW; Egevad L

Article: VIRCHOWS ARCHIV. 2020;477(6):777-786

Identification of areas of grading difficulties in prostate cancer and comparison with artificial intelligence assisted grading

Egevad L; Swanberg D; Delahunt B; Strom P; Kartasalo K; Olsson H; Berney DM; Bostwick DG; Evans AJ; Humphrey PA; Iczkowski KA; Kench JG; Kristiansen G; Leite KRM; McKenney JK; Oxley J; Pan C-C; Samaratunga H; Srigley JR; Takahashi H; Tsuzuki T; van der Kwast T; Varma M; Zhou M; Clements M; Eklund M

Article: JOURNAL OF CLINICAL PATHOLOGY. 2020;73(10):630-635

Prognostic value of perineural invasion in prostate needle biopsies: a population-based study of patients treated by radical prostatectomy

Strom P; Nordstrom T; Delahunt B; Samaratunga H; Gronberg H; Egevad L; Eklund M

Article: HISTOPATHOLOGY. 2020;77(2):284-292

Perineural invasion by prostate adenocarcinoma in needle biopsies predicts bone metastasis: Ten year data from the TROG 03.04 RADAR Trial

Delahunt B; Murray JD; Steigler A; Atkinson C; Christie D; Duchesne G; Egevad L; Joseph D; Matthews J; Oldmeadow C; Samaratunga H; Spry NA; Srigley JR; Hondermarck H; Denham JW

Article: PATHOLOGY. 2020;52(5):507-514

Granular necrosis: a distinctive form of cell death in malignant tumours

Samaratunga H; Delahunt B; Srigley JR; Berney DM; Cheng L; Evans A; Furusat B; Leite KRM; MacLennan GT; Martignoni G; Moch H; Pan C-C; Paner G; Ro J; Thunders M; Tsuzuki T; Wheeler T; Kwast TVD; Varma M; Williamson SR; Yaxley JW; Egevad L

Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2020;44(7):e15-e29

Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers. I. Molecular Biomarkers in Prostate Cancer

Lotan TL; Tomlins SA; Bismar TA; Van der Kwast TH; Grignon D; Egevad L; Kristiansen G; Pritchard CC; Rubin MA; Bubendorf L

Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2020;44(7):e47-e65

Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers III: Molecular Pathology of Kidney Cancer

Williamson SR; Gill AJ; Argani P; Chen Y-B; Egevad L; Kristiansen G; Grignon DJ; Hes O

Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2020;44(7):e66-e79

Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers IV: Current and Future Utilization of Molecular-Genetic Tests for Testicular Germ Cell Tumors

Looijenga LHJ; Van der Kwast TH; Grignon D; Egevad L; Kristiansen G; Kao C-S; Idrees MT

Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2020;44(7):859-861

The International Society of Urological Pathology Consultation on Molecular Pathology of Urogenital Cancer

van der Kwast TH; Egevad L; Kristiansen G; Grignon DJ

Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2020;44(7):e80-e86

Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers V Recommendations on the Use of Immunohistochemical and Molecular Biomarkers in Penile Cancer

Canete-Portillo S; Velazquez EF; Kristiansen G; Egevad L; Grignon D; Chaux A; Cubilla AL

Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2020;44(7):e30-e46

Report From the International Society of Urological Pathology (ISUP) Consultation Conference On Molecular Pathology Of Urogenital Cancers. II. Molecular Pathology of Bladder Cancer Progress and Challenges

Warrick JI; Knowles MA; Yves A; van der Kwast T; Grignon DJ; Kristiansen G; Egevad L; Hartmann A; Cheng L

Article: JOURNAL OF PATHOLOGY. 2020;250(4):387-396

Perivascular Neuropilin-1 expression is an independent marker of improved survival in renal cell carcinoma

Morin E; Lindskog C; Johansson M; Egevad L; Sandstrom P; Harmenberg U; Claesson-Welsh L; Sjoberg E

Article: LANCET ONCOLOGY. 2020;21(2):222-232

Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study

Strom P; Kartasalo K; Olsson H; Solorzano L; Delahunt B; Berney DM; Bostwick DG; Evans AJ; Grignon DJ; Humphrey PA; Iczkowski KA; Kench JG; Kristiansen G; van der Kwast TH; Leite KRM; McKenney JK; Oxley J; Pan C-C; Samaratunga H; Srigley JR; Takahashi H; Tsuzuki T; Varma M; Zhou M; Lindberg J; Lindskog C; Ruusuvuori P; Wahlby C; Gronberg H; Rantalainen M; Egevad L; Eklund M

Article: BJU INTERNATIONAL. 2020;125(2):270-275

The natural history of untreated muscle-invasive bladder cancer

Martini A; Sfakianos JP; Renstrom-Koskela L; Mortezavi A; Falagario UG; Egevad L; Hosseini A; Mehrazin R; Galsky MD; Steineck G; Wiklund NP

Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2020;54(1):1-6

Lower urinary tract symptoms (LUTS) are not associated with an increased risk of prostate cancer in men 50-69 years with PSA ≥3 ng/ml

Engel JC; Palsdottir T; Aly M; Egevad L; Gronberg H; Eklund M; Nordstrom T

Article: CELL DEATH DISCOVERY. 2020;6(1):42

Interleukin-6 derived from cancer-associated fibroblasts attenuates the p53 response to doxorubicin in prostate cancer cells

Cheteh EH; Sarne V; Ceder S; Bianchi J; Augsten M; Rundqvist H; Egevad L; Ostman A; Wiman KG

Article: MODERN PATHOLOGY. 2019;32(9):1310-1319

Immunoreactivity for prostate specific antigen and Ki67 differentiates subgroups of prostate cancer related to outcome

Hammarsten P; Josefsson A; Thysell E; Lundholm M; Hagglof C; Iglesias-Gato D; Flores-Morales A; Stattin P; Egevad L; Granfors T; Wikstrom P; Bergh A

Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2019;43(9):1249-1252

Is the UICC/AJCC pT2 Staging Category for Clear Cell Renal Cell Carcinoma Meaningful?

Delahunt B; Dagher J; Egevad L; Yaxley J; Varma M; Samaratunga H

Article: BMJ OPEN. 2019;9(8):e027860

PCASTt/SPCG-17-a randomised trial of active surveillance in prostate cancer: rationale and design

Ahlberg MS; Adami H-O; Beckmann K; Bertilsson H; Bratt O; Cahill D; Egevad L; Garmo H; Holmberg L; Johansson E; Rannikko A; Van Hemelrijck M; Jaderling F; Wassberg C; Aberg UWN; Bill-Axelson A

Article: MOLECULAR ONCOLOGY. 2019;13(8):1763-1777

Gene expression profiles define molecular subtypes of prostate cancer bone metastases with different outcomes and morphology traceable back to the primary tumor

Thysell E; Vidman L; Ylitalo EB; Jernberg E; Crnalic S; Iglesias-Gato D; Flores-Morales A; Stattin P; Egevad L; Widmark A; Ryden P; Bergh A; Wikstrom P

Article: APMIS. 2019;127(8):554-560

PD-L1 expression and deficient mismatch repair in ductal adenocarcinoma of the prostate

Lindh C; Kis L; Delahunt B; Samaratunga H; Yaxley J; Wiklund NP; Clements M; Egevad L

Article: PATHOLOGY. 2019;51(4):349-352

Percentage grade 4 tumour predicts outcome for clear cell renal cell carcinoma

Dagher J; Delahunt B; Rioux-Leclercq N; Egevad L; Varma M; Samaratunga H

Article: PROSTATE. 2019;79(8):920-928

Somatic alterations detected in diagnostic prostate biopsies provide an inadequate representation of multifocal prostate cancer

Kristiansen A; Bergstrom R; Delahunt B; Samaratunga H; Gudjonsdottir J; Gronberg H; Egevad L; Lindberg J

Article: VIRCHOWS ARCHIV. 2019;474(5):577-584

The International Society of Urological Pathology Education weba web-based system for training and testing of pathologists

Egevad L; Delahunt B; Samaratunga H; Leite KRM; Efremovs G; Furusato B; Han M; Jufe L; Tsuzuki T; Wang Z; Hornblad J; Clements M

Article: HISTOPATHOLOGY. 2019;74(6):844-852

Handling and reporting of pelvic lymphadenectomy specimens in prostate and bladder cancer: a web-based survey by the European Network of Uropathology

Prendeville S; Berney DM; Bubendorf L; Comperat E; Egevad L; Hes O; Kristiansen G; Oxley J; van Leenders GJLH; Varma M; van der Kwast T

Article: PROSTATE. 2019;79(5):435-445

Prostate cancer induces C/EBP expression in surrounding epithelial cells which relates to tumor aggressiveness and patient outcome

Adamo H; Hammarsten P; Hagglof C; Scherdin TD; Egevad L; Stattin P; Bergstrom SH; Bergh A

Article: JOURNAL OF UROLOGY. 2019;201(4):815-820

Outcomes of Primary Lymph Node Staging of Intermediate and High Risk Prostate Cancer with ⁶⁸Ga-PSMA Positron Emission Tomography/Computerized Tomography Compared to Histological Correlation of Pelvic Lymph Node Pathology

Yaxley JW; Raveenthiran S; Nouhaud F-X; Samartunga H; Yaxley AJ; Coughlin G; Delahunt B; Egevad L; McEwan L; Wong D

Article: PLOS ONE. 2019;14(6):e0218280

Are Prostate Specific-Antigen (PSA) and age associated with the risk of ISUP Grade 1 prostate cancer? Results from 72 996 individual biopsy cores in 6 083 men from the Stockholm3 study

Palsdottir T; Nordstrom T; Aly M; Lindberg J; Clements M; Egevad L; Gronberg H; Eklund M

Article: PATHOLOGY. 2019;51(1):11-20

Dataset for the reporting of prostate carcinoma in core needle biopsy and transurethral resection and enucleation specimens: recommendations from the International Collaboration on Cancer Reporting (ICCR)

Egevad L; Judge M; Delahunt B; Humphrey PA; Kristiansen G; Oxley J; Rasiah K; Takahashi H; Trpkov K; Varma M; Wheeler TM; Zhou M; Srigley JR; Kench JG

Article: HISTOPATHOLOGY. 2019;74(2):284-290

Assessment of tumour-associated necrosis provides prognostic information additional to World Health Organization/International Society of Urological Pathology grading for clear cell renal cell carcinoma

Dagher J; Delahunt B; Rioux-Leclercq N; Egevad L; Coughlin G; Dunglison N; Gianduzzo T; Kua B; Malone G; Martin B; Preston J; Pokorny M; Wood S; Samaratunga H

Article: GENOME MEDICINE. 2018;10(1):85

Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis

Mayrhofer M; De Laere B; Whitington T; Van Oyen P; Ghysel C; Ampe J; Ost P; Demey W; Hoekx L; Schrijvers D; Brouwers B; Lybaert W; Everaert E; De Maeseneer D; Strijbos M; Bols A; Fransis K; Oeyen S; van Dam P-J; Van den Eynden G; Rutten A; Aly M; Nordstrom T; Van Laere S; Rantalainen M; Rajan P; Egevad L; Ullen A; Yachnin J; Dirix L; Gronberg H; Lindberg J

Article: BRITISH JOURNAL OF CANCER. 2018;119(7):840-846

A minority-group of renal cell cancer patients with high infiltration of CD20+B-cells is associated with poor prognosis

Sjoberg E; Frodin M; Lovrot J; Mezheyeuski A; Johansson M; Harmenberg U; Egevad L; Sandstrom P; Ostman A

Article: EUROPEAN UROLOGY FOCUS. 2018;4(5):707-710

The Stockholm-3 (STHLM3) Model can Improve Prostate Cancer Diagnostics in Men Aged 50-69 yr Compared with Current Prostate Cancer Testing

Eklund M; Nordstrom T; Aly M; Adolfsson J; Wiklund P; Brandberg Y; Thompson J; Wiklund F; Lindberg J; Presti JC; StLezin M; Clements M; Egevad L; Gronberg H

Article: EUROPEAN UROLOGY. 2018;74(2):204-210

The Stockholm-3 Model for Prostate Cancer Detection: Algorithm Update, Biomarker Contribution, and Reflex Test Potential

Strom P; Nordstrom T; Aly M; Egevad L; Gronberg H; Eklund M

Article: HISTOPATHOLOGY. 2018;73(1):8-18

Utility of Pathology Imagebase for standardisation of prostate cancer grading

Egevad L; Delahunt B; Berney DM; Bostwick DG; Cheville J; Comperat E; Evans AJ; Fine SW; Grignon DJ; Humphrey PA; Hornblad J; Iczkowski KA; Kench JG; Kristiansen G; Leite KRM; Magi-Galluzzi C; McKenney JK; Oxley J; Pan C-C; Samaratunga H; Srigley JR; Takahashi H; True LD; Tsuzuki T; van der Kwast T; Varma M; Zhou M; Clements M

Article: PATHOLOGY. 2018;50(4):382-388

Macroscopic features of prostate cancer

Lindh C; Delahunt B; Egevad L

Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2018;42(6):e33-e43

Intraoperative Consultation and Macroscopic Handling The International Society of Urological Pathology (ISUP) Testicular Cancer Consultation Conference Recommendations

Verrill C; Perry-Keene J; Srigley JR; Zhou M; Humphrey PA; Lopez-Beltran A; Egevad L; Ulbright TM; Tickoo SK; Epstein JI; Comperat E; Berney DM

Article: VIRCHOWS ARCHIV. 2018;472(4):599-604

Handling and reporting of transperineal template prostate biopsy in Europe: a web-based survey by the European Network of Uropathology (ENUP)

Kammerer-Jacquet S-F; Comperat E; Egevad L; Hes O; Oxley J; Varma M; Kristiansen G; Berney DM

Article: EUROPEAN UROLOGY FOCUS. 2018;4(3):385-387

Balancing Overdiagnosis and Early Detection of Prostate Cancer using the Stockholm-3 Model

Nordstrom T; Gronberg H; Adolfsson J; Egevad L; Aly M; Eklund M

Article: EUROPEAN UROLOGY FOCUS. 2018;4(3):351-359

Oncologic Outcomes After Robot-assisted Radical Prostatectomy: A Large European Single-centre Cohort with Median 10-Year Follow-up

Rajan P; Hagman A; Sooriakumaran P; Nyberg T; Wallerstedt A; Adding C; Akre O; Carlsson S; Hosseini A; Olsson M; Egevad L; Wiklund F; Steineck G; Wiklund NP

Article: HISTOPATHOLOGY. 2018;72(3):481-489

A novel technique for biobanking of large sections of radical prostatectomy specimens

Lindh C; Delahunt B; Samaratunga H; Yaxley J; Gudjonsdottir J; Clements M; Lindberg J; Egevad L

Article: WORLD JOURNAL OF UROLOGY. 2018;36(1):15-20

Reconsidering the role of pelvic lymph node dissection with radical prostatectomy for prostate cancer in an era of improving radiological staging techniques

Yaxley JW; Dagher J; Delahunt B; Egevad L; Srigley J; Samaratunga H

Article: PATHOLOGY. 2017;49(7):715-720

Prognostic significance and biopsy characteristics of prostate cancer with seminal vesicle invasion on radical prostatectomy: a nationwide population-based study

Kristiansen A; Drevin L; Delahunt B; Samaratunga H; Robinson D; Lissbrant IF; Stattin P; Egevad L

Article: HISTOPATHOLOGY. 2017;71(6):918-925

Clear cell renal cell carcinoma: validation of World Health Organization/International Society of Urological Pathology grading

Dagher J; Delahunt B; Rioux-Leclercq N; Egevad L; Srigley JR; Coughlin G; Dunglinson N; Gianduzzo T; Kua B; Malone G; Martin B; Preston J; Pokorny M; Wood S; Yaxley J; Samaratunga H

Article: JOURNAL OF CLINICAL ONCOLOGY. 2017;35(31):3566-3574

Effect of Comorbidity on Prostate Cancer-Specific Mortality: A Prospective Observational Study

Rajan P; Sooriakumaran P; Nyberg T; Akre O; Carlsson S; Egevad L; Steineck G; Wiklund NP

Article: HISTOPATHOLOGY. 2017;71(5):677-685

Pathology Imagebase-a reference image database for standardization of pathology

Egevad L; Cheville J; Evans AJ; Hornblad J; Kench JG; Kristiansen G; Leite KRM; Magi-Galluzzi C; Pan C-C; Samaratunga H; Srigley JR; True L; Zhou M; Clements M; Delahunt B

Article: HUMAN PATHOLOGY. 2017;69:1-7

Genetic profile of ductal adenocarcinoma of the prostate

Seipel AH; Whitington T; Delahunt B; Samaratunga H; Mayrhofer M; Wiklund P; Gronberg H; Lindberg J; Egevad L

Article: HISTOPATHOLOGY. 2017;71(4):641-647

Mucinous adenocarcinoma of prostate and prostatic adenocarcinoma with mucinous components: a clinicopathological analysis of 143 cases

Samaratunga H; Delahunt B; Srigley JR; Yaxley J; Johannsen S; Coughlin G; Gianduzzo T; Kua B; Patterson I; Nacey JN; Egevad L

Article: ONCOTARGET. 2017;8(36):60257-60269

Characterization of infiltrating lymphocytes in human benign and malignant prostate tissue

Radestad E; Egevad L; Jorns C; Mattsson J; Sundberg B; Nava S; Ericzon B-G; Henningsohn L; Levitsky V; Uhlin M

Article: EUROPEAN UROLOGY. 2017;72(1):22-31

Translating a Prognostic DNA Genomic Classifier into the Clinic: Retrospective Validation in 563 Localized Prostate Tumors

Lalonde E; Alkallas R; Chua MLK; Fraser M; Haider S; Meng A; Zheng J; Yao CQ; Picard V; Orain M; Hovington H; Murgic J; Berlin A; Lacombe L; Bergeron A; Fradet Y; Tetu B; Lindberg J; Egevad L; Gronberg H; Ross-Adams H; Lamb AD; Halim S; Dunning MJ; Neal DE; Pintilie M; van der Kwast T; Bristow RG; Boutros PC

Article: CELL DEATH & DISEASE. 2017;8(6):e2848

Human cancer-associated fibroblasts enhance glutathione levels and antagonize drug-induced prostate cancer cell death

Cheteh EH; Augsten M; Rundqvist H; Bianchi J; Sarne V; Egevad L; Bykov VJN; Ostman A; Wiman KG

Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2017;41(6):e22-e32

Reporting and Staging of Testicular Germ Cell Tumors The International Society of Urological Pathology (ISUP) Testicular Cancer Consultation Conference Recommendations

Verrill C; Yilmaz A; Srigley JR; Amin MB; Comperat E; Egevad L; Ulbright TM; Tickoo SK; Berney DM; Epstein JI; Delahunt B; Magi-Galluzzi C; Algaba F; Oliva E; Montironi R; Young RH; Idrees MT; Williamson SR; Zhou M; Humphrey PA; Lopez-Beltran A; Perry-Keene J

Article: EUROPEAN UROLOGY. 2017;71(5):776-787

Subgroups of Castration-resistant Prostate Cancer Bone Metastases Defined Through an Inverse Relationship Between Androgen Receptor Activity and Immune Response

Ylitalo EB; Thysell E; Jernberg E; Lundholm M; Crnalic S; Egevad L; Stattin P; Widmark A; Bergh A; Wikstrom P

Article: SCIENTIFIC REPORTS. 2017;7:44876

Loss of chromosome Y leads to down regulation of KDM5D and KDM6C epigenetic modifiers in clear cell renal cell carcinoma

Arseneault M; Monlong J; Vasudev NS; Laskar RS; Safisamghabadi M; Harnden P; Egevad L; Nourbehesht N; Panichnantakul P; Holcatova I; Brisuda A; Janout V; Kollarova H; Foretova L; Navratilova M; Mates D; Jinga V; Zaridze D; Mukeria A; Jandaghi P; Brennan P; Brazma A; Tost J; Scelo G; Banks RE; Lathrop M; Bourque G; Riazalhosseini Y

Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2017;41(2):253-262

Rhabdoid and Undifferentiated Phenotype in Renal Cell Carcinoma Analysis of 32 Cases Indicating a Distinctive Common Pathway of Dedifferentiation Frequently Associated With SWI/SNF Complex Deficiency

Agaimy A; Cheng L; Egevad L; Feyerabend B; Hes O; Keck B; Pizzolitto S; Sioletic S; Wullich B; Hartmann A

Article: BRITISH JOURNAL OF CANCER. 2017;116(2):195-201

Perivascular PDGFR-β is an independent marker for prognosis in renal cell carcinoma

Frodin M; Mezheyeuski A; Corvigno S; Harmenberg U; Sandstrom P; Egevad L; Johansson M; Ostman A

Article: BJU INTERNATIONAL. 2017;119(1):50-56

Accuracy of prostate biopsies for predicting Gleason score in radical prostatectomy specimens: nationwide trends 2000-2012

Danneman D; Drevin L; Delahunt B; Samaratunga H; Robinson D; Bratt O; Loeb S; Stattin P; Egevad L

Article: SCIENTIFIC REPORTS. 2016;6:36149

Image analysis-derived metrics of histomorphological complexity predicts prognosis and treatment response in stage II-III colon cancer

Mezheyeuski A; Hrynchyk I; Karlberg M; Portyanko A; Egevad L; Ragnhammar P; Edler D; Glimelius B; Ostman A

Article: JOURNAL OF SURGICAL ONCOLOGY. 2016;114(6):664-670

Prognostic Implications of 2005 Gleason Grade Modification. Population-Based Study of Biochemical Recurrence Following Radical Prostatectomy

Thomsen FB; Folkvaljon Y; Brasso K; Loeb S; Robinson D; Egevad L; Stattin P

Article: JOURNAL OF CLINICAL PATHOLOGY. 2016;69(10):852-857

Intraductal carcinoma of prostate reporting practice: a survey of expert European uropathologists

Varma M; Egevad L; Algaba F; Berney D; Bubendorf L; Camparo P; Comperat E; Erbersdobler A; Griffiths D; Grobholz R; Haitel A; Hulsbergen-van de Kaa C; Langner C; Loftus B; Lopez-Beltran A; Mayer N; Nesi G; Oliveira P; Oxley J; Rioux-Leclercq N; Seitz G; Shanks J; Kristiansen G

Article: HISTOPATHOLOGY. 2016;69(3):441-449

Gleason grade 4 prostate adenocarcinoma patterns: an interobserver agreement study among genitourinary pathologists

Kweldam CF; Nieboer D; Algaba F; Amin MB; Berney DM; Billis A; Bostwick DG; Bubendorf L; Cheng L; Comperat E; Delahunt B; Egevad L; Evans AJ; Hansel DE; Humphrey PA; Kristiansen G; van der Kwast TH; Magi-Galluzzi C; Montironi R; Netto GJ; Samaratunga H; Srigley JR; Tan PH; Varma M; Zhou M; van Leenders GJLH

Article: EUROPEAN UROLOGY. 2016;69(6):1135-1141

Evaluation of the 2015 Gleason Grade Groups in a Nationwide Population-based Cohort

Loeb S; Folkvaljon Y; Robinson D; Lissbrant IF; Egevad L; Stattin P

Article: MOLECULAR ONCOLOGY. 2016;10(6):825-837

Large-scale evaluation of SLC18A2 in prostate cancer reveals diagnostic and prognostic biomarker potential at three molecular levels

Haldrup C; Lynnerup A-S; Storebjerg TM; Vang S; Wild P; Visakorpi T; Arsov C; Schulz WA; Lindberg J; Groenberg H; Egevad L; Borre M; Orntoft TF; Hoyer S; Sorensen KD

Article: EUROPEAN UROLOGY. 2016;69(5):942-952

The Proteome of Primary Prostate Cancer

Iglesias-Gato D; Wikstrom P; Tyanova S; Lavallee C; Thysell E; Carlsson J; Hagglof C; Cox J; Andren O; Stattin P; Egevad L; Widmark A; Bjartell A; Collins CC; Bergh A; Geiger T; Mann M; Flores-Morales A

Article: BJU INTERNATIONAL. 2016;117:7-8

Prostate cancer grading: recent developments and future directions

Delahunt B; Egevad L; Grignon DJ; Srigley JR; Samaratunga H

Article: APMIS. 2016;124(4):263-270

Immunohistochemistry of ductal adenocarcinoma of the prostate and adenocarcinomas of non-prostatic origin: a comparative study

Seipel AH; Samaratunga H; Delahunt B; Wiklund P; Clements M; Egevad L

Article: NATURE GENETICS. 2016;48(4):387-397

Gene regulatory mechanisms underpinning prostate cancer susceptibility

Whitington T; Gao P; Song W; Ross-Adams H; Lamb AD; Yang Y; Svezia I; Klevebring D; Mills IG; Karlsson R; Halim S; Dunning MJ; Egevad L; Warren AY; Neal DE; Gronberg H; Lindberg J; Wei G-H; Wiklund F

Article: HISTOPATHOLOGY. 2016;68(4):533-540

Pleomorphic giant cell carcinoma of the urinary bladder: an extreme form of tumour de-differentiation

Samaratunga H; Delahunt B; Egevad L; Adamson M; Hussey D; Malone G; Hoyle K; Nathan T; Kerle D; Ferguson P; Nacey JN

Article: EUROPEAN UROLOGY. 2016;69(3):428-435

A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score

Epstein JI; Zelefsky MJ; Sjoberg DD; Nelson JB; Egevad L; Magi-Galluzzi C; Vickers AJ; Parwani AV; Reuter VE; Fine SW; Eastham JA; Wiklund P; Han M; Reddy CA; Ciezki JP; Nyberg T; Klein EA

Article: PATHOLOGE. 2016;37(1):17-26

The 2014 consensus conference of the ISUP on Gleason grading of prostatic carcinoma

Kristiansen G; Egevad L; Amin M; Delahunt B; Srigley JR; Humphrey PA; Epstein JI

Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2016;40(2):244-252

The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma Definition of Grading Patterns and Proposal for a New Grading System

Epstein JI; Egevad L; Amin MB; Delahunt B; Srigley JR; Humphrey PA

Article: PLOS ONE. 2016;11(10):e0164016

High Caveolin-1 Expression in Tumor Stroma Is Associated with a Favourable Outcome in Prostate Cancer Patients Managed by Watchful Waiting

Hammarsten P; Scherdin TD; Hagglof C; Andersson P; Wikstrom P; Stattin P; Egevad L; Granfors T; Bergh A

Article: LANCET ONCOLOGY. 2015;16(16):1667-1676

Prostate cancer screening in men aged 50-69 years (STHLM3): a prospective population-based diagnostic study

Gronberg H; Adolfsson J; Aly M; Nordstrom T; Wiklund P; Brandberg Y; Thompson J; Wiklund F; Lindberg J; Clements M; Egevad L; Eklund M

Article: ONCOTARGET. 2015;6(35):37066-37082

Sorafenib-induced defective autophagy promotes cell death by necroptosis

Kharaziha P; Chioureas D; Baltatzis G; Fonseca P; Rodriguez P; Gogvadze V; Lennartsson L; Bjorklund A-C; Zhivotovsky B; Grander D; Egevad L; Nilsson S; Panaretakis T

Article: SCIENTIFIC REPORTS. 2015;5:15651

Secreted Factors from Colorectal and Prostate Cancer Cells Skew the Immune Response in Opposite Directions

Lundholm M; Hagglof C; Wikberg ML; Stattin P; Egevad L; Bergh A; Wikstrom P; Palmqvist R; Edin S

Article: PATHOLOGY. 2015;47(6):520-525

Validation of International Society of Urological Pathology (ISUP) grading for prostatic adenocarcinoma in thin core biopsies using TROG 03.04 'RADAR' trial clinical data

Delahunt B; Egevad L; Srigley JR; Steigler A; Murray JD; Atkinson C; Matthews J; Duchesne G; Spry NA; Christie D; Joseph D; Attia J; Denham JW

Article: PATHOLOGY. 2015;47(6):515-519

The prognostic significance of the 2014 International Society of Urological Pathology (ISUP) grading system for prostate cancer

Samaratunga H; Delahunt B; Gianduzzo T; Coughlin G; Duffy D; LeFevre I; Johannsen S; Egevad L; Yaxley J

Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2015;39(10):1331-1339

Diagnosis of "Poorly Formed Glands" Gleason Pattern 4 Prostatic Adenocarcinoma on Needle Biopsy An Interobserver Reproducibility Study Among Urologic Pathologists With Recommendations

Zhou M; Li J; Cheng L; Egevad L; Deng F-M; Kunju LP; Magi-Galluzzi C; Melamed J; Mehra R; Mendrinos S; Osunkoya AO; Paner G; Shen SS; Tsuzuki T; Trpkov K; Tian W; Yang X; Shah RB

Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2015;39(9):1242-1249

Diagnosis of Gleason Pattern 5 Prostate Adenocarcinoma on Core Needle Biopsy An Interobserver Reproducibility Study Among Urologic Pathologists

Shah RB; Li J; Cheng L; Egevad L; Deng F-M; Fine SW; Kunju LP; Melamed J; Mehra R; Osunkoya AO; Paner GP; Shen SS; Tsuzuki T; Trpkov K; Tian W; Yang XJ; Zhou M

Article: HISTOPATHOLOGY. 2015;67(3):313-324

Handling and reporting of orchidectomy specimens with testicular cancer: areas of consensus and variation among 25 experts and 225 European pathologists

Berney DM; Algaba F; Amin M; Delahunt B; Comperat E; Epstein JI; Humphrey P; Idrees M; Lopez-Beltran A; Magi-Galluzzi C; Mikuz G; Montironi R; Oliva E; Srigley J; Reuter VE; Trpkov K; Ulbright TM; Varma M; Verrill C; Young RH; Zhou M; Egevad L

Article: EBIOMEDICINE. 2015;2(9):1133-1144

Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study

Ross-Adams H; Lamb AD; Dunning MJ; Halim S; Lindberg J; Massie CM; Egevad LA; Russell R; Ramos-Montoya A; Vowler SL; Sharma NL; Kay J; Whitaker H; Clark J; Hurst R; Gnanapragasam VJ; Shah NC; Warren AY; Cooper CS; Lynch AG; Stark R; Mills IG; Groenberg H; Neal DE

Article: BJU INTERNATIONAL. 2015;116(2):213-219

Upper limit of cancer extent on biopsy defining very low-risk prostate cancer

Bratt O; Folkvaljon Y; Loeb S; Klotz L; Egevad L; Stattin P

Article: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2015;34(1):62

Confrontation of fibroblasts with cancer cells in vitro: gene network analysis of transcriptome changes and differential capacity to inhibit tumor growth

Alexeyenko A; Alkasalias T; Pavlova T; Szekely L; Kashuba V; Rundqvist H; Wiklund P; Egevad L; Csermely P; Korcsmaros T; Guven H; Klein G

Article: EUROPEAN UROLOGY. 2015;67(5):819-822

Tracking the Origin of Metastatic Prostate Cancer

Lindberg J; Kristiansen A; Wiklund P; Gronberg H; Egevad L

Article: BJU INTERNATIONAL. 2015;115(2):248-255

Gleason inflation 1998-2011: a registry study of 97 168 men

Danneman D; Drevin L; Robinson D; Stattin P; Egevad L

Article: MOLECULAR CANCER. 2015;14(1):8

OTUB1 de-ubiquitinating enzyme promotes prostate cancer cell invasion in vitro and tumorigenesis in vivo

Iglesias-Gato D; Chuan Y-C; Jiang N; Svensson C; Bao J; Paul I; Egevad L; Kessler BM; Wikstorm P; Niu Y; Flores-Morales A

Article: PLOS ONE. 2015;10(10):e0140985

High Lysyl Oxidase (LOX) in the Non-Malignant Prostate Epithelium Predicts a Poor Outcome in Prostate Cancer Patient Managed by Watchful Waiting

Nilsson M; Hagglof C; Hammarsten P; Thysell E; Stattin P; Egevad L; Granfors T; Jernberg E; Wikstrom P; Bergstrom SH; Bergh A

Article: BJU INTERNATIONAL. 2015;115(1):106-113

The impact of length and location of positive margins in predicting biochemical recurrence after robot-assisted radical prostatectomy with a minimum follow-up of 5 years

Sooriakumaran P; Ploumidis A; Nyberg T; Olsson M; Akre O; Haendler L; Egevad L; Nilsson A; Carlsson S; Jonsson M; Adding C; Hosseini A; Steineck G; Wiklund P

Article: ANNALS OF DIAGNOSTIC PATHOLOGY. 2014;18(6):333-342

Intraductal carcinoma of the prostate: interobserver reproducibility survey of 39 urologic pathologists

Iczkowski KA; Egevad L; Ma J; Harding-Jackson N; Algaba F; Billis A; Camparo P; Cheng L; Clouston D; Comperat EM; Datta MW; Evans AG; Griffiths DF; Guo CC; Hailemariam S; Huang W; Humphrey PA; Jiang Z; Kahane HR; Kristiansen G; La Rosa FG; Lopez-Beltran A; MacLennan GT; Magi-Galluzzi C; Merrimen J; Montironi R; Osunkoya AO; Picken MM; Rao N; Shah RB; Shanks JH; Shen SS; Tawfik OW; True LD; Van der Kwast T; Varma M; Wheeler TM; Zynger DL; Sahr N; Bostwick DG

Article: ANNALES DE PATHOLOGIE. 2014;34(6):448-461

Renal tumors: The International Society of Urologic Pathology (ISUP) 2012 consensus conference recommendations

Rioux-Leclercq N; Ferran A; Mahul A; Argani P; Billis A; Bonsib S; Cheng L; Cheville J; Eble J; Egevad L; Epstein J; Grignon D; Hes O; Humphrey P; Magi-Galluzzi C; Martignoni G; McKenney J; Merino M; Moch H; Montironi R; Netto G; Reuter V; Samaratunga H; Shen S; Srigley J; Tamboli P; Tan PH; Tickoo S; Trpkov K; Zhou M; Delahunt B; Comperat E

Article: VIRCHOWS ARCHIV. 2014;465(6):623-628

Consensus statement with recommendations on active surveillance inclusion criteria and definition of progression in men with localized prostate cancer: the critical role of the pathologist

Montironi R; Hammond EH; Lin DW; Gore JL; Srigley JR; Samaratunga H; Egevad L; Rubin MA; Nacey J; Klotz L; Sandler H; Zietman AL; Holden S; Humphrey PA; Evans AJ; Delahunt B; McKenney JK; Berney D; Wheeler TM; Chinnaiyan A; True L; Knudsen B; Epstein JI; Amin MB

Article: ONCOGENE. 2014;33(45):5274-5287

N-acetyl-L-aspartyl-L-glutamate peptidase-like 2 is overexpressed in cancer and promotes a pro-migratory and pro-metastatic phenotype

Whitaker HC; Shiong LL; Kay JD; Groenberg H; Warren AY; Seipel A; Wiklund F; Thomas B; Wiklund P; Miller JL; Menon S; Ramos-Montoya A; Vowler SL; Massie C; Egevad L; Neal DE

Article: VIRCHOWS ARCHIV. 2014;465(5):559-565

Immunohistochemical profile of ductal adenocarcinoma of the prostate

Seipel AH; Samaratunga H; Delahunt B; Wiklund F; Wiklund P; Lindberg J; Gronberg H; Egevad L

Article: NATURE COMMUNICATIONS. 2014;5:5135

Variation in genomic landscape of clear cell renal cell carcinoma across Europe

Scelo G; Riazalhosseini Y; Greger L; Letourneau L; Gonzalez-Porta M; Wozniak MB; Bourgey M; Harnden P; Egevad L; Jackson SM; Karimzadeh M; Arseneault M; Lepage P; How-Kit A; Daunay A; Renault V; Blanche H; Tubacher E; Sehmoun J; Viksna J; Celms E; Opmanis M; Zarins A; Vasudev NS; Seywright M; Abedi-Ardekani B; Carreira C; Selby PJ; Cartledge JJ; Byrnes G; Zavadil J; Su J; Holcatova I; Brisuda A; Zaridze D; Moukeria A; Foretova L; Navratilova M; Mates D; Jinga V; Artemov A; Nedoluzhko A; Mazur A; Rastorguev S; Boulygina E; Heath S; Gut M; Bihoreau M-T; Lechner D; Foglio M; Gut IG; Skryabin K; Prokhortchouk E; Cambon-Thomsen A; Rung J; Bourque G; Brennan P; Tost J; Banks RE; Brazma A; Lathrop GM

Article: ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE. 2014;138(10):1387-1405

The Critical Role of the Pathologist in Determining Eligibility for Active Surveillance as a Management Option in Patients With Prostate Cancer Consensus Statement With Recommendations Supported by the College of American Pathologists, International Society of Urological Pathology, Association of Directors of Anatomic and Surgical Pathology, the New Zealand Society of Pathologists, and the Prostate Cancer Foundation

Amin MB; Lin DW; Gore JL; Srigley JR; Samaratunga H; Egevad L; Rubin M; Nacey J; Carter HB; Klotz L; Sandler H; Zietman AL; Holden S; Montironi R; Humphrey PA; Evans AJ; Epstein JI; Delahunt B; McKenney JK; Berney D; Wheeler TM; Chinnaiyan AM; True L; Knudsen B; Hammond MEH

Article: PROSTATE. 2014;74(14):1391-1399

Novel Method to Characterize Immune Cells From Human Prostate Tissue

Norstrom MM; Radestad E; Stikvoort A; Egevad L; Bergqvist M; Henningsohn L; Mattsson J; Levitsky V; Uhlin M

Article: HUMAN PATHOLOGY. 2014;45(9):1805-1812

Seminal vesicle intraepithelial involvement by prostate cancer: putative mechanism and clinicopathological significance

Miyai K; Kristiansen A; Egevad L; Pina-Oviedo S; Divatia MK; Shen SS; Miles BJ; Ayala AG; Park YW; Ro JY

Article: HISTOPATHOLOGY. 2014;65(2):216-227

Diagnostic criteria for ductal adenocarcinoma of the prostate: interobserver variability among 20 expert uropathologists

Seipel AH; Delahunt B; Samaratunga H; Amin M; Barton J; Berney DM; Billis A; Cheng L; Comperat E; Evans A; Fine SW; Grignon D; Humphrey PA; Magi-Galluzzi C; Montironi R; Sesterhenn I; Srigley JR; Trpkov K; van der Kwast T; Varma M; Zhou M; Ahmad A; Moss S; Egevad L

Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2014;38(8):e50-e59

Best Practices Recommendations in the Application of Immunohistochemistry in Testicular Tumors Report From the International Society of Urological Pathology Consensus Conference

Ulbright TM; Tickoo SK; Berney DM; Srigley JR; Amin MB; Epstein JI; Humphrey PA; Egevad L; Montironi R; Grignon D; Trpkov K; Lopez-Beltran A; Zhou M; Argani P; Delahunt B; Reuter VE

Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2014;38(8):e6-e19

Best Practices Recommendations in the Application of Immunohistochemistry in the Prostate Report From the International Society of Urologic Pathology Consensus Conference

Epstein JI; Egevad L; Humphrey PA; Montironi R; Amin MB; Ulbright TM; Grignon D; Trpkov K; Lopez-Beltran A; Zhou M; Argani P; Delahunt B; Berney DM; Srigley JR; Tickoo SK; Reuter VE

Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2014;38(8):e35-e49

Best Practices Recommendations in the Application of Immunohistochemistry in the Kidney Tumors Report From the International Society of Urologic Pathology Consensus Conference

Reuter VE; Argani P; Zhou M; Delahunt B

Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2014;38(8):1017-1022

Best Practices Recommendations in the Application of Immunohistochemistry in Urologic Pathology Report From the International Society of Urological Pathology Consensus Conference

Amin MB; Epstein JI; Ulbright TM; Humphrey PA; Egevad L; Montironi R; Grignon D; Trpkov K; Lopez-Beltran A; Zhou M; Argani P; Delahunt B; Berney DM; Srigley JR; Tickoo SK; Reuter VE

Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2014;38(8):e20-e34

Best Practices Recommendations in the Application of Immunohistochemistry in the Bladder Lesions Report From the International Society of Urologic Pathology Consensus Conference

Amin MB; Trpkov K; Lopez-Beltran A; Grignon D; Epstein JI; Ulbright TM; Humphrey PA; Egevad L; Montironi R; Zhou M; Argani P; Delahunt B; Berney DM; Srigley JR; Tickoo S; Reuter VE

Article: EUROPEAN JOURNAL OF CANCER. 2014;50(10):1829-1835

High density of S100A9 positive inflammatory cells in prostate cancer stroma is associated with poor outcome

Tidehag V; Hammarsten P; Egevad L; Grantors T; Stattin P; Leanderson T; Wikstrom P; Josefsson A; Hagglof C; Bergh A

Article: CANCER RESEARCH. 2014;74(13):3408-3417

Local and Systemic Protumorigenic Effects of Cancer-Associated Fibroblast-Derived GDF15

Bruzzese F; Hagglof C; Leone A; Sjoberg E; Roca MS; Kiflemariam S; Sjoblom T; Hammarsten P; Egevad L; Bergh A; Ostman A; Budillon A; Augsten M

Article: EUROPEAN UROLOGY. 2014;65(6):1184-1190

A Genetic Score Can Identify Men at High Risk for Prostate Cancer Among Men With Prostate-Specific Antigen of 1-3 ng/ml

Nordstrom T; Aly M; Eklund M; Egevad L; Gronberg H

Article: UROLOGY. 2014;83(5):969-974

Advances in Renal Neoplasia

Delahunt B; Srigley JR; Montironi R; Egevad L

Article: VIRCHOWS ARCHIV. 2014;464(5):583-587

Variation in reporting of cancer extent and benign histology in prostate biopsies among European pathologists

Berney DM; Algaba F; Camparo P; Comperat E; Griffiths D; Kristiansen G; Lopez-Beltran A; Montironi R; Varma M; Egevad L

Article: CLINICAL CANCER RESEARCH. 2014;20(8):2169-2181

Hypermethylation of the GABRE∼miR-452∼miR-224 Promoter in Prostate Cancer Predicts Biochemical Recurrence after Radical Prostatectomy

Kristensen H; Haldrup C; Strand S; Mundbjerg K; Mortensen MM; Thorsen K; Ostenfeld MS; Wild PJ; Arsov C; Goering W; Visakorpi T; Egevad L; Lindberg J; Groenberg H; Hoyer S; Borre M; Orntoft TF; Sorensen KD

Article: NATURE GENETICS. 2014;46(2):126-135

A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding

Huang Q; Whitington T; Gao P; Lindberg JF; Yang Y; Sun J; Vaisanen M-R; Szulkin R; Annala M; Yan J; Egevad LA; Zhang K; Lin R; Jolma A; Nykter M; Manninen A; Wiklund F; Vaarala MH; Visakorpi T; Xu J; Taipale J; Wei G-H

Article: HISTOPATHOLOGY. 2014;64(3):405-411

The reasons behind variation in Gleason grading of prostatic biopsies: areas of agreement and misconception among 266 European pathologists

Berney DM; Algaba F; Camparo P; Comperat E; Griffiths D; Kristiansen G; Lopez-Beltran A; Montironi R; Varma M; Egevad L

Article: PLOS ONE. 2014;9(2):e86824

TMPRSS2-ERG Expression Predicts Prostate Cancer Survival and Associates with Stromal Biomarkers

Hagglof C; Hammarsten P; Stromvall K; Egevad L; Josefsson A; Stattin P; Granfors T; Bergh A

Article: PATHOLOGY. 2014;46(1):11-14

Clinical significance of cancer in radical prostatectomy specimens: analysis from a contemporary series of 2900 men

Samaratunga H; Delahunt B; Yaxley J; Perry-Keene J; Lamb DS; Srigley JR; Egevad L; Nacey JN

Article: PLOS ONE. 2014;9(9):e105063

ErbB2 Receptor Immunoreactivity in Prostate Cancer: Relationship to the Androgen Receptor, Disease Severity at Diagnosis and Disease Outcome

Hammarsten P; Winther J; Rudolfsson SH; Haggstrom J; Karalija A; Egevad L; Granfors T; Fowler CJ

Article: PLOS ONE. 2014;9(8):e104417

Evaluation of Exome Sequencing to Estimate Tumor Burden in Plasma

Klevebring D; Neiman M; Sundling S; Eriksson L; Ramqvist ED; Celebioglu F; Czene K; Hall P; Egevad L; Groenberg H; Lindberg J

Article: CARCINOGENESIS. 2014;35(1):24-33

SOCS2 mediates the cross talk between androgen and growth hormone signaling in prostate cancer

Iglesias-Gato D; Chuan Y-C; Wikstrom P; Augsten S; Jiang N; Niu Y; Seipel A; Danneman D; Vermeij M; Fernandez-Perez L; Jenster G; Egevad L; Norstedt G; Flores-Morales A

Article: HISTOPATHOLOGY. 2013;63(6):756-766

An interobserver reproducibility study on invasiveness of bladder cancer using virtual microscopy and heatmaps

Comperat E; Egevad L; Lopez-Beltran A; Camparo P; Algaba F; Amin M; Epstein JI; Hamberg H; Hulsbergen-van de Kaa C; Kristiansen G; Montironi R; Pan C-C; Heloir F; Treurniet K; Sykes J; Van der Kwast TH

Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2013;37(10):1518-1531

Renal Tumors Diagnostic and Prognostic Biomarkers

Tan PH; Cheng L; Rioux-Leclercq N; Merino MJ; Netto G; Reuter VE; Shen SS; Grignon DJ; Montironi R; Egevad L; Srigley JR; Delahunt B; Moch H

Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2013;37(10):1505-1517

Handling and Staging of Renal Cell Carcinoma The International Society of Urological Pathology Consensus (ISUP) Conference Recommendations

Trpkov K; Grignon DJ; Bonsib SM; Amin MB; Billis A; Lopez-Beltran A; Samaratunga H; Tamboli P; Delahunt B; Egevad L; Montironi R; Srigley JR

Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2013;37(10):1490-1504

The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic Parameters

Delahunt B; Cheville JC; Martignoni G; Humphrey PA; Magi-Galluzzi C; McKenney J; Egevad L; Algaba F; Moch H; Grignon DJ; Montironi R; Srigley JR

Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2013;37(10):1469-1489

The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia

Srigley JR; Delahunt B; Eble JN; Egevad L; Epstein JI; Grignon D; Hes O; Moch H; Montironi R; Tickoo SK; Zhou M; Argani P

Article: HISTOPATHOLOGY. 2013;63(4):580-589

Prognostic significance of histopathological features of extraprostatic extension of prostate cancer

Danneman D; Wiklund F; Wiklund NP; Egevad L

Article: CANCER. 2013;119(13):2405-2412

Genetic markers associated with early cancer-specific mortality following prostatectomy

Liu W; Xie CC; Thomas CY; Kim S-T; Lindberg J; Egevad L; Wang Z; Zhang Z; Sun J; Sun J; Koty PP; Kader AK; Cramer SD; Bova GS; Zheng SL; Groenberg H; Isaacs WB; Xu J

Article: HISTOPATHOLOGY. 2013;62(7):1049-1056

Prognostic significance of patterns of seminal vesicle invasion in prostate cancer

Kristiansen A; Wiklund F; Wiklund P; Egevad L

Article: ANNALES DE PATHOLOGIE. 2013;33(3):155-161

International Society of Urological Pathology (ISUP) Consensus Conference on handling and staging of radical prostatectomy specimens

Comperat E; Camparo P; Srigley J; Delahunt B; Egevad L; Amin M; Berney DM; Billis A; Cheng L; Epstein J; Evans A; Grignon D; Humphrey P; Magi-Galuzzi C; Montironi R; Samaratunga H; Tan PH; True L; van der Kwast T; Wheeler T

Article: VIRCHOWS ARCHIV. 2013;462(4):429-436

Histopathological features of ductal adenocarcinoma of the prostate in 1,051 radical prostatectomy specimens

Seipel AH; Wiklund F; Wiklund NP; Egevad L

Article: EUROPEAN UROLOGY. 2013;63(4):702-708

The Mitochondrial and Autosomal Mutation Landscapes of Prostate Cancer

Lindberg J; Mills IG; Klevebring D; Liu W; Neiman M; Xu J; Wikstrom P; Wiklund P; Wiklund F; Egevad L; Gronberg H

Article: PATHOLOGY. 2013;45(3):243-250

Premalignant lesions of the urinary bladder

Samaratunga H; Martignoni G; Egevad L; Delahunt B

Article: CLINICAL CANCER RESEARCH. 2013;19(6):1547-1556

Castration Therapy Results in Decreased Ku70 Levels in Prostate Cancer

Al-Ubaidi FLT; Schultz N; Loseva O; Egevad L; Granfors T; Helleday T

Article: HUMAN PATHOLOGY. 2013;44(3):310-319

Nuclear Stat5a/b predicts early recurrence and prostate cancer-specific death in patients treated by radical prostatectomy

Mirtti T; Leiby BE; Abdulghani J; Aaltonen E; Pavela M; Mamtani A; Alanen K; Egevad L; Granfors T; Josefsson A; Stattin P; Bergh A; Nevalainen MT

Article: JOURNAL OF CLINICAL PATHOLOGY. 2013;66(2):120-123

Prostate needle biopsy processing: a survey of laboratory practice across Europe

Varma M; Berney DM; Algaba F; Camparo P; Comperat E; Griffiths DFR; Kristiansen G; Lopez-Beltran A; Montironi R; Egevad L

Article: EUROPEAN UROLOGY. 2013;63(2):347-353

Exome Sequencing of Prostate Cancer Supports the Hypothesis of Independent Tumour Origins

Lindberg J; Klevebring D; Liu W; Neiman M; Xu J; Wiklund P; Wiklund F; Mills IG; Egevad L; Gronberg H

Article: HISTOPATHOLOGY. 2013;62(2):247-256

Standardization of Gleason grading among 337 European pathologists

Egevad L; Ahmad AS; Algaba F; Berney DM; Boccon-Gibod L; Comperat E; Evans AJ; Griffiths D; Grobholz R; Kristiansen G; Langner C; Lopez-Beltran A; Montironi R; Moss S; Oliveira P; Vainer B; Varma M; Camparo P

Article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. 2012;46(6):405-410

Current routines for transrectal ultrasound-guided prostate biopsy: A web-based survey by the Swedish Urology Network

Carlsson S; Bratt O; Stattin P; Egevad L

Article: EUROPEAN UROLOGY. 2012;62(5):768-774

Biochemical Recurrence After Robot-assisted Radical Prostatectomy in a European Single-centre Cohort with a Minimum Follow-up Time of 5 Years

Sooriakumaran P; Haendler L; Nyberg T; Gronberg H; Nilsson A; Carlsson S; Hosseini A; Adding C; Jonsson M; Ploumidis A; Egevad L; Steineck G; Wiklund P

Article: EUROPEAN JOURNAL OF CANCER. 2012;48(17):3267-3277

Fruit and vegetable consumption and risk of aggressive and non-aggressive urothelial cell carcinomas in the European Prospective Investigation into Cancer and Nutrition

Ros MM; Bueno-de-Mesquita HB; Kampman E; Buchner FL; Aben KKH; Egevad L; Overvad K; Tjonneland A; Roswall N; Clavel-Chapelon F; Boutron-Ruault MC; Morois S; Kaaks R; Teucher B; Weikert S; von Ruesten A; Trichopoulou A; Naska A; Benetou V; Saieva C; Pala V; Ricceri F; Tumino R; Mattiello A; Peeters PHM; van Gils CH; Gram IT; Engeset D; Chirlaque M-D; Ardanazx E; Rodriguez L; Amanio P; Gonzalez CA; Jose Sanchez M; Ulmert D; Ernstrom R; Ljungberg B; Allen NE; Key TJ; Khaw K-T; Wareham N; Slimani N; Romieu I; Kiemeney LA; Riboli E

Article: AMERICAN JOURNAL OF CLINICAL NUTRITION. 2012;96(4):902-910

Plasma carotenoids and vitamin C concentrations and risk of urothelial cell carcinoma in the European Prospective Investigation into Cancer and Nutrition

Ros MM; Bueno-de-Mesquita HB; Kampman E; Aben KKH; Buechner FL; Jansen EHJM; van Gils CH; Egevad L; Overvad K; Tjonneland A; Roswall N; Boutron-Ruault MC; Kvaskoff M; Perquier F; Kaaks R; Chang-Claude J; Weikert S; Boeing H; Trichopoulou A; Lagiou P; Dilis V; Palli D; Pala V; Sacerdote C; Tumino R; Panico S; Peeters PHM; Gram IT; Skeie G; Huerta JM; Barricarte A; Quiros JR; Sanchez MJ; Buckland G; Larranaga N; Ehrnstroem R; Wallstroem P; Jungberg BL; Hallmans G; Key TJ; Allen NE; Khaw K-T; Wareham N; Brennan P; Riboli E; Kiemeney LA

Article: ONCOGENE. 2012;31(35):3939-3948

Identification of novel CHD1-associated collaborative alterations of genomic structure and functional assessment of CHD1 in prostate cancer

Liu W; Lindberg J; Sui G; Luo J; Egevad L; Li T; Xie C; Wan M; Kim S-T; Wang Z; Turner AR; Zhang Z; Feng J; Yan Y; Sun J; Bova GS; Ewing CM; Yan G; Gielzak M; Cramer SD; Vessella RL; Zheng SL; Gronberg H; Isaacs WB; Xu J

Article: CANCER MEDICINE. 2012;1(1):96-104

Emphasizing the role of Wnt5a protein expression to predict favorable outcome after radical prostatectomy in patients with low-grade prostate cancer

Khaja ASS; Egevad L; Helczynski L; Wiklund P; Andersson T; Bjartell A

Article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. 2012;46(4):247-257

Low endoglin vascular density and Ki67 index in Gleason score 6 tumours may identify prostate cancer patients suitable for surveillance

Josefsson A; Wikstrom P; Egevad L; Granfors T; Karlberg L; Stattin P; Bergh A

Article: PATHOLOGE. 2012;33(4):337-344

Diagnostics of radical prostatectomy specimens. Results of the 2009 consensus conference of the International Society of Urological Pathology

Kristiansen G; Srigley JR; Delahunt B; Egevad L

Article: ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE. 2012;136(4):426-434

Implications of the International Society of Urological Pathology Modified Gleason Grading System

Egevad L; Mazzucchelli R; Montironi R

Article: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2012;82(3):1243-1248

CASTRATION THERAPY OF PROSTATE CANCER RESULTS IN DOWNREGULATION OF HIF-1α LEVELS

Al-Ubaidi FLT; Schultz N; Egevad L; Granfors T; Helleday T

Article: JOURNAL OF CLINICAL PATHOLOGY. 2012;65(2):106-113

Handling and reporting of nephrectomy specimens for adult renal tumours: a survey by the European Network of Uropathology

Algaba F; Delahunt B; Berney DM; Camparo P; Comperat E; Griffiths D; Kristiansen G; Lopez-Beltran A; Martignoni G; Moch H; Montironi R; Varma M; Egevad L

Article: CELL DEATH & DISEASE. 2012;3(1):e262

Targeting of distinct signaling cascades and cancer-associated fibroblasts define the efficacy of Sorafenib against prostate cancer cells

Kharaziha P; Rodriguez P; Li Q; Rundqvist H; Bjoerklund A-C; Augsten M; Ullen A; Egevad L; Wiklund P; Nilsson S; Kroemer G; Grander D; Panaretakis T

Article: PLOS ONE. 2012;7(10):e47994

Phospho-Akt Immunoreactivity in Prostate Cancer: Relationship to Disease Severity and Outcome, Ki67 and Phosphorylated EGFR Expression

Hammarsten P; Cipriano M; Josefsson A; Stattin P; Egevad L; Granfors T; Fowler CJ

Article: PLOS ONE. 2012;7(10):e48455

Identification of New Differentially Methylated Genes That Have Potential Functional Consequences in Prostate Cancer

Kim JW; Kim S-T; Turner AR; Young T; Smith S; Liu W; Lindberg J; Egevad L; Gronberg H; Isaacs WB; Xu J

Article: AMERICAN JOURNAL OF PATHOLOGY. 2011;179(4):1961-1968

Prostate Cancer Increases Hyaluronan in Surrounding Nonmalignant Stroma, and This Response Is Associated with Tumor Growth and an Unfavorable Outcome

Josefsson A; Adamo H; Hammarsten P; Granfors T; Stattin P; Egevad L; Laurent AE; Wikstrom P; Bergh A

Article: PATHOLOGY INTERNATIONAL. 2011;61(9):536-538

Solitary fibrous tumor of the prostate: A report of two cases

Talvitie H; Astrom K; Larsson O; Ahlen J; Bergh A; Egevad L

Article: VIRCHOWS ARCHIV. 2011;459(2):175-182

Interactive digital slides with heat maps: a novel method to improve the reproducibility of Gleason grading

Egevad L; Algaba F; Berney DM; Boccon-Gibod L; Comperat E; Evans AJ; Grobholz R; Kristiansen G; Langner C; Lockwood G; Lopez-Beltran A; Montironi R; Oliveira P; Schwenkglenks M; Vainer B; Varma M; Verger V; Camparo P

Article: INTERNATIONAL JOURNAL OF CANCER. 2011;128(12):2843-2852

LRIG1 and the liar paradox in prostate cancer: a study of the expression and clinical significance of LRIG1 in prostate cancer

Thomasson M; Wang B; Hammarsten P; Dahlman A; Persson JL; Josefsson A; Stattin P; Granfors T; Egevad L; Henriksson R; Bergh A; Hedman H

Article: INTERNATIONAL JOURNAL OF CANCER. 2011;128(12):2971-2979

Variety in vegetable and fruit consumption and risk of bladder cancer in the European Prospective Investigation into Cancer and Nutrition

Buchner FL; Bueno-de-Mesquita HB; Ros MM; Kampman E; Egevad L; Overvad K; Tjonneland A; Roswall N; Clavel-Chapelon F; Boutron-Ruault M-C; Touillaud M; Kaaks R; Chang-Claude J; Boeing H; Weikert S; Trichopoulou A; Naska A; Benetou V; Palli D; Sieri S; Vineis P; Tumino R; Panico S; van Duijnhoven FJB; Peeters PHM; van Gils CH; Lund E; Gram IT; Sanchez M-J; Jakszyn P; Larranaga N; Ardanaz E; Navarro C; Rodriguez L; Manjer J; Ehrnstrom R; Hallmans G; Ljungberg B; Key TJ; Allen NE; Khaw K-T; Wareham N; Slimani N; Jenab M; Boffetta P; Kiemeney LALM; Riboli E

Article: INTERNATIONAL JOURNAL OF CANCER. 2011;128(11):2695-2708

Fluid intake and the risk of urothelial cell carcinomas in the European Prospective Investigation into Cancer and Nutrition (EPIC)

Ros MM; Bueno-de-Mesquita HBB; Buchner FL; Aben KKH; Kampman E; Egevad L; Overvad K; Tjonneland A; Roswall N; Clavel-Chapelon F; Kaaks R; Chang-Claude J; Boeing H; Weikert S; Trichopoulou A; Orfanos P; Stasinopulou G; Saieva C; Krogh V; Vineis P; Tumino R; Mattiello A; Peeters PHM; van Duijnhoven FJB; Lund E; Gram IT; Chirlaque MD; Barricarte A; Rodriguez L; Molina E; Gonzalez C; Dorronsoro M; Manjer J; Ehrnstrom R; Ljungberg B; Allen NE; Roddam AW; Khaw K-T; Wareham N; Boffetta P; Slimani N; Michaud DS; Kiemeney LALM; Riboli E

Article: HISTOPATHOLOGY. 2011;58(4):579-585

Handling and reporting of transurethral resection specimens of the bladder in Europe: a web-based survey by the European Network of Uropathology (ENUP)

Lopez-Beltran A; Algaba F; Berney DM; Boccon-Gibod L; Camparo P; Griffiths D; Mikuz G; Montironi R; Varma M; Egevad L

Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2011;20(3):555-559

Red Meat, Dietary Nitrosamines, and Heme Iron and Risk of Bladder Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)

Jakszyn P; Gonzalez CA; Lujan-Barroso L; Ros MM; Bueno-de-Mesquita HB; Roswall N; Tjonneland AM; Buchner FL; Egevad L; Overvad K; Raaschou-Nielsen O; Clavel-Chapelon F; Boutron-Ruault M-C; Touillaud MS; Chang-Claude J; Allen NE; Kiemeney LA; Key TJ; Kaaks R; Boeing H; Weikert S; Trichopoulou A; Oikonomou E; Zylis D; Palli D; Berrino F; Vineis P; Tumino R; Mattiello A; Peeters PHM; Parr CL; Gram IT; Skeie G; Sanchez M-J; Larranaga N; Ardanaz E; Navarro C; Rodriguez L; Ulmert D; Ehrnstrom R; Hallmans G; Ljungberg B; Roddam AW; Bingham SA; Khaw K-T; Slimani N; Boffetta PA; Jenab M; Mouw T; Michaud DS; Riboli E

Article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. 2011;45(1):39-45

GAD1 is a biomarker for benign and malignant prostatic tissue

Jaraj SJ; Augsten M; Haggarth L; Wester K; Ponten F; Ostman A; Egevad L

Article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. 2011;45(1):60-67

Diagnostic biomarkers of prostate cancer

Haggarth L; Hagglof C; Jaraj SJ; Wester K; Ponten F; Ostman A; Egevad L

Article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. 2010;44(6):371-377

Beta-tubulin III expression in prostate cancer

Egevad L; Valdman A; Wiklund NP; Seve P; Dumontet C

Article: JOURNAL OF UROLOGY. 2010;184(4):1322-1327

Outcome of Primary Versus Deferred Radical Prostatectomy in the National Prostate Cancer Register of Sweden Follow-Up Study

Holmstrom B; Holmberg E; Egevad L; Adolfsson J; Johansson J-E; Hugosson J; Stattin P

Article: PLOS ONE. 2010;5(8):e12275

Fatty Acid Amide Hydrolase in Prostate Cancer: Association with Disease Severity and Outcome, CB₁ Receptor Expression and Regulation by IL-4

Thors L; Bergh A; Persson E; Hammarsten P; Stattin P; Egevad L; Granfors T; Fowler CJ

Article: AMERICAN JOURNAL OF PATHOLOGY. 2010;177(2):1031-1041

Mast Cells Are Novel Independent Prognostic Markers in Prostate Cancer and Represent a Target for Therapy

Johansson A; Rudolfsson S; Hammarsten P; Halin S; Pietras K; Jones J; Stattin P; Egevad L; Granfors T; Wikstrom P; Bergh A

Article: CARCINOGENESIS. 2010;31(8):1475-1482

Effects of the TP53 p.R249S mutant on proliferation and clonogenic properties in human hepatocellular carcinoma cell lines: interaction with hepatitis B virus X protein

Gouas DA; Shi H; Hautefeuille AH; Ortiz-Cuaran SL; Legros PC; Szymanska KJ; Galy O; Egevad LA; Abedi-Ardekani B; Wiman KG; Hantz O; de Fromentel CC; Chemin IA; Hainaut PL

Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2010;102(13):950-958

Outcomes in Localized Prostate Cancer: National Prostate Cancer Register of Sweden Follow-up Study

Stattin P; Holmberg E; Johansson J-E; Holmberg L; Adolfsson J; Hugosson J

Article: APMIS. 2010;118(5):383-388

Formalin fixation and immunoreactivity in prostate cancer and benign prostatic tissues

Jaraj SJ; Egevad L

Article: APMIS. 2010;118(5):360-365

Distribution of Foxp3-, CD4-and CD8-positive lymphocytic cells in benign and malignant prostate tissue

Valdman A; Jaraj SJ; Comperat E; Charlotte F; Roupret M; Pisa P; Egevad L

Article: NATURE. 2010;464(7291):993-998

International network of cancer genome projects

Hudson TJ; Anderson W; Aretz A; Barker AD; Bell C; Bernabe RR; Bhan MK; Calvo F; Eerola I; Gerhard DS; Guttmacher A; Guyer M; Hemsley FM; Jennings JL; Kerr D; Klatt P; Kolar P; Kusuda J; Lane DP; Laplace F; Lu Y; Nettekoven G; Ozenberger B; Peterson J; Rao TS; Remacle J; Schafer AJ; Shibata T; Stratton MR; Vockley JG; Watanabe K; Yang H; Yuen MMF; Knoppers M; Bobrow M; Cambon-Thomsen A; Dressler LG; Dyke SOM; Joly Y; Kato K; Kennedy KL; Nicolas P; Parker MJ; Rial-Sebbag E; Romeo-Casabona CM; Shaw KM; Wallace S; Wiesner GL; Zeps N; Lichter P; Biankin AV; Chabannon C; Chin L; Clement B; de Alava E; Degos F; Ferguson ML; Geary P; Hayes DN; Johns AL; Nakagawa H; Penny R; Piris MA; Sarin R; Scarpa A; van de Vijver M; Futreal PA; Aburatani H; Bayes M; Bowtell DDL; Campbell PJ; Estivill X; Grimmond SM; Gut I; Hirst M; Lopez-Otin C; Majumder P; Marra M; Ning Z; Puente XS; Ruan Y; Stunnenberg HG; Swerdlow H; Velculescu VE; Wilson RK; Xue HH; Yang L; Spellman PT; Bader GD; Boutros PC; Flicek P; Getz G; Guigo R; Guo G; Haussler D; Heath S; Hubbard TJ; Jiang T; Jones SM; Li Q; Lopez-Bigas N; Luo R; Pearson JV; Quesada V; Raphael BJ; Sander C; Speed TP; Stuart JM; Teague JW; Totoki Y; Tsunoda T; Valencia A; Wheeler DA; Wu H; Zhao S; Zhou G; Stein LD; Lathrop M; Ouellette BFF; Thomas G; Yoshida T; Axton M; Gunter C; McPherson JD; Miller LJ; Kasprzyk A; Zhang J; Haider SA; Wang J; Yung CK; Cross A; Liang Y; Gnaneshan S; Guberman J; Hsu J; Chalmers DRC; Hasel KW; Kaan TSH; Knoppers BM; Lowrance WW; Masui T; Rodriguez LL; Vergely C; Cloonan N; Defazio A; Eshleman JR; Etemadmoghadam D; Gardiner BA; Kench JG; Sutherland RL; Tempero MA; Waddell NJ; Wilson PJ; Gallinger S; Tsao M-S; Shaw PA; Petersen GM; Mukhopadhyay D; DePinho RA; Thayer S; Muthuswamy L; Shazand K; Beck T; Sam M; Timms L; Ballin V; Ji J; Zhang X; Chen F; Hu X; Yang Q; Tian G; Zhang L; Xing X; Li X; Zhu Z; Yu Y; Yu J; Tost J; Brennan P; Holcatova I; Zaridze D; Brazma A; Egevad L; Prokhortchouk E; Banks RE; Uhlen M; Viksna J; Ponten F; Skryabin K; Birney E; Borg A; Borresen-Dale A-L; Caldas C; Foekens JA; Martin S; Reis-Filho JS; Richardson AL; Sotiriou C; van't Veer L; Birnbaum D; Blanche H; Boucher P; Boyault S; Masson-Jacquemier JD; Pauporte I; Pivot X; Vincent-Salomon A; Tabone E; Theillet C; Treilleux I; Bioulac-Sage P; Decaens T; Franco D; Gut M; Samuel D; Zucman-Rossi J; Eils R; Brors B; Korbel JO; Korshunov A; Landgraf P; Lehrach H; Pfister S; Radlwimmer B; Reifenberger G; Taylor MD; von Kalle C; Majumder PP; Pederzoli P; Lawlor RT; Delledonne M; Bardelli A; Gress T; Klimstra D; Zamboni G; Nakamura Y; Miyano S; Fujimoto A; Campo E; de Sanjose S; Montserrat E; Gonzalez-Diaz M; Jares P; Himmelbaue H; Bea S; Aparicio S; Easton DF; Collins FS; Compton CC; Lander ES; Burke W; Green AR; Hamilton SR; Kallioniemi OP; Ley TJ; Liu ET; Wainwright BJ

Article: CLINICAL CANCER RESEARCH. 2010;16(4):1245-1255

Low Levels of Phosphorylated Epidermal Growth Factor Receptor in Nonmalignant and Malignant Prostate Tissue Predict Favorable Outcome in Prostate Cancer Patients

Hammarsten P; Karalija A; Josefsson A; Rudolfsson SH; Wikstrom P; Egevad L; Granfors T; Stattin P; Bergh A

Article: CELLULAR ONCOLOGY. 2010;32(1):39-44

Clinical Significance of Intratumoral CD8+ Regulatory T Cells in Prostate Carcinoma

Comperat E; Egevad L; Camparo P; Roupret M; Vaessen C; Valdman A; Jonmarker S; Capron F; Cussenot O; Charlotte F

Article: CELLULAR ONCOLOGY. 2009;31(6):367-374

Expression of Redox Pathway Enzymes in Human Prostatic Tissue

Valdman A; Haggarth L; Cheng L; Lopez-Beltran A; Montironi R; Ekman P; Egevad L

Article: INTERNATIONAL JOURNAL OF CANCER. 2009;125(11):2643-2651

Consumption of vegetables and fruit and the risk of bladder cancer in the European Prospective Investigation into Cancer and Nutrition

Buechner FL; Bueno-de-Mesquita HB; Ros MM; Kampman E; Egevad L; Overvad K; Raaschou-Nielsen O; Tjonneland A; Roswall N; Clavel-Chapelon F; Boutron-Ruault M-C; Touillaud M; Chang-Claude J; Kaaks R; Boeing H; Weikert S; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Sieri S; Vineis P; Tumino R; Panico S; Vrieling A; Peeters PHM; van Gils CH; Lund E; Gram IT; Engeset D; Martinez C; Gonzalez CA; Larranaga N; Ardanaz E; Navarro C; Rodriguez L; Manjer J; Ehrnstrom RA; Hallmans G; Ljungberg B; Allen NE; Roddam AW; Bingham S; Khaw K-T; Slimani N; Boffetta P; Jenab M; Mouw T; Michaud DS; Kiemeney LALM; Riboli E

Article: ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE. 2009;133(10):1568-1576

Protocol for the Examination of Specimens From Patients With Carcinoma of the Prostate Gland

Srigley JR; Humphrey PA; Amin MB; Chang SS; Egevad L; Epstein JI; Grignon DJ; McKiernan JM; Montironi R; Renshaw AA; Reuter VE; Wheeler TM

Article: VIRCHOWS ARCHIV. 2009;455(4):375-381

Intra- and interobserver reproducibility of interpretation of immunohistochemical stains of prostate cancer

Jaraj SJ; Camparo P; Boyle H; Germain F; Nilsson B; Petersson F; Egevad L

Article: INTERNATIONAL JOURNAL OF CANCER. 2009;125(4):902-908

Physical activity and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort

Johnsen NF; Tjonneland A; Thomsen BLR; Christensen J; Loft S; Friedenreich C; Key TJ; Allen NE; Lahmann PH; Mejlvig L; Overvad K; Kaaks R; Rohrmann S; Boing H; Misirli G; Trichopoulou A; Zylis D; Tumino R; Pala V; Bueno-de-Mesquita HB; Kiemeney LA; Rodriguez Suarez L; Gonzalez CA; Sanchez M-J; Maria Huerta J; Barricarte Gurrea A; Manjer J; Wirfalt E; Khaw K-T; Wareham N; Boffetta P; Egevad L; Rinaldi S; Riboli E

Article: CELLULAR ONCOLOGY. 2009;31(3):137-142

Endothelin-1 Expression in Prostate Cancer and High Grade Prostatic Intraepithelial Neoplasia

Rosenblatt R; Valdman A; Cheng L; Lopez-Beltran A; Montironi R; Ekman P; Egevad L

Article: CELLULAR ONCOLOGY. 2009;31(2):90-95

The European Network of Uropathology A Novel Mechanism for Communication Between Pathologists

Egevad L; Algaba F; Berney DM; Boccon-Gibod L; Griffiths DF; Lopez-Beltran A; Mikuz G; Varma M; Montironi R

Article: CELLULAR ONCOLOGY. 2009;31(2):74-82

Expression of Immunomodulating Genes in Prostate Cancer and Benign Prostatic Tissue

Reschner A; Harlin H; Laven B; Eriksson F; Pisa P; Egevad L

Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2009;106(9):3414-3419

CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth

Augsten M; Hagglof C; Olsson E; Stolz C; Tsagozis P; Levchenko T; Frederick MJ; Borg A; Micke P; Egevad L; Ostman A

Article: EUROPEAN JOURNAL OF CANCER. 2009;45(1):174-182

A high cannabinoid CB₁ receptor immunoreactivity is associated with disease severity and outcome in prostate cancer

Chung SC; Hammarsten P; Josefsson A; Stattin P; Granfors T; Egevad L; Mancini G; Lutz B; Bergh A; Fowler CJ

Article: INTERNATIONAL JOURNAL OF CANCER. 2009;124(1):245-249

A prospective analysis of the association between dietary fiber intake and prostate cancer risk in EPIC

Suzuki R; Allen NE; Key TJ; Appleby PN; Tjonneland A; Johnsenz NF; Jensen MK; Overvad K; Boeing H; Pischon T; Kaaks R; Rohrmann S; Trichopoulou A; Misirli G; Trichopoulos D; Bueno-de-Mesquita HB; van Duijnhoven F; Sacerdote C; Pala V; Palli D; Tumino R; Ardanaz E; Quiros JR; Larranaga N; Sanchez M-J; Tormo M-J; Jakszyn P; Johansson I; Stattin P; Berglund G; Manjer J; Bingham S; Khaw K-T; Egevad L; Ferrari P; Jenab M; Riboli E

Article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. 2009;43(1):88-91

Urachal signet-cell adenocarcinoma

Egevad L; Hakansson U; Grabe M; Ehrnstrom R

Article: APMIS. 2008;116(10):888-895

Heat shock proteins 27, 60 and 70 as prognostic markers of prostate cancer

Glaessgen A; Jonmarker S; Lindberg A; Nilsson B; Lewensohn R; Ekman P; Valdman A; Egevad L

Article: CELLULAR ONCOLOGY. 2008;30(5):254-260

Recent Trends in Gleason Grading of Prostate Cancer II. Prognosis, Reproducibility and Reporting

Egevad L

Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2008;32(10):1532-1539

Grading of invasive cribriform carcinoma on prostate needle biopsy - An interobserver study among experts in genitourinary pathology

Latour M; Amin MB; Billis A; Egevad L; Grignon DJ; Humphrey PA; Reuter VE; Sakr WA; Srigley JR; Wheeler TM; Yang XJ; Epstein JI

Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2008;32(10):1503-1512

Interobserver variability between expert: Urologic pathologists for extraprostatic extension and surgical margin status in radical prostatectomy specimens

Evans AJ; Henry PC; Van der Kwast TH; Tkachuk DC; Watson K; Lockwood GA; Fleshner NE; Cheung C; Belanger EC; Amin MB; Boccon-Gibod L; Bostwick DG; Egevad L; Epstein JI; Grignon DJ; Jones EC; Montironi R; Moussa M; Sweet JM; Trpkov K; Wheeler TM; Srigley JR

Article: AMERICAN JOURNAL OF CLINICAL PATHOLOGY. 2008;130(3):375-381

Quantitative assessment of the subepithelial collagen band does not increase the accuracy of diagnosis of collagenous colitis

Rubio CA; Orrego A; Hoog A; Porwitz A; F'etersson F; Elmberger G; Glaessgen A; Eriksson E; Kanter L; Jaremko G; Egevad L; Laforga J; Liljefors M; Lofdahl B; Norman P; Larsson O; Wanat R; Wejde J; Zickert P; Bjork J; Caini S; Palli D; Nesi G

Article: HISTOPATHOLOGY. 2008;53(3):333-339

Handling and reporting of radical prostatectomy specimens in Europe: a web-based survey by the European Network of Uropathology (ENUP)

Egevad L; Algaba F; Berney DM; Boccon-Gibod L; Griffiths DF; Lopez-Beltran A; Mikuz G; Varma M; Montironi R

Article: CELLULAR ONCOLOGY. 2008;30(4):190-198

Recent trends in Gleason grading of prostate cancer - I. Pattern interpretation

Egevad L

Article: APMIS. 2008;116(6):491-498

Expression of PDX-1 in prostate cancer, prostatic intraepithelial neoplasia and benign prostatic tissue

Jonmarker S; Glaessgen A; Culp WD; Pisa P; Lewensohn R; Ekman P; Valdman A; Egevad L

Article: CELLULAR ONCOLOGY. 2008;30(3):133-138

Correlation of modified gleason grading of prostate carcinoma with age, serum prostate specific antigen and tumor extent in needle biopsy specimens

Helpap B; Egevad L

Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2008;17(5):1282-1287

Alcohol consumption and the risk for prostate cancer in the European prospective investigation into cancer and nutrition

Rohrmann S; Linseisen J; Key TJ; Jensen MK; Overvad K; Johnsen NF; Tjonneland A; Kaaks R; Bergmann MM; Weikert C; Naska A; Trichopoulou A; Trichopoulos D; Pala V; Sacerdote C; Palli D; Tumino R; Bueno-de-Mesquita HB; Vrieling A; Gonzalez CA; Larranaga N; Navarro C; Barricarte A; Quiros JR; Martinez-Garcia C; Hallmans G; Stattin P; Manjer J; Wirfalt E; Bingham S; Khaw K-T; Egevad L; Ferrari P; Jenab M; Riboli E

Article: BJU INTERNATIONAL. 2008;101(3):293-298

Computer-aided ultrasonography (HistoScanning): a novel technology for locating and characterizing prostate cancer

Braeckman J; Autier P; Garbar C; Marichal MP; Soviany C; Nir R; Nir D; Michielsen D; Bleiberg H; Egevad L; Emberton M

Article: CELLULAR ONCOLOGY. 2008;30(1):1-7

Correlation of modified Gleason grading with pT stage of prostatic carcinoma after radical prostatectomy

Helpap B; Egevad L

Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2008;17(2):279-285

Circulating concentrations of folate and vitamin B₁₂ in relation to prostate cancer risk:: Results from the European Prospective Investigation into Cancer and Nutrition study

Johansson M; Appleby PN; Allen NE; Travis RC; Roddam AW; Egevad L; Jenab M; Rinaldi S; Kiemeney LA; Bueno-de-Mesquita HB; Vollset SE; Ueland PM; Sanchez M-J; Quiros JR; Gonzalez CA; Larranaga N; Chirlaque MD; Ardanaz E; Sieri S; Palli D; Vineis P; Tumino R; Linseisen J; Kaaks R; Boeing H; Pischon T; Psaltopouiou T; Trichopouiou A; Trichopoulos D; Khaw K-T; Bingham S; Hallmans G; Riboli E; Stattin P; Key TJ

Article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. 2008;42(5):484-487

Atypical stromal hyperplasia of the prostate

Egevad L; Carbin B-E; Castellanos E; Hellstrom M; Valdman A

Article: INTERNATIONAL JOURNAL OF CANCER. 2007;121(6):1331-1338

Serum androgens and prostate cancer among 643 cases and 643 controls in the European Prospective Investigation into Cancer and Nutrition

Travis RC; Key TJ; Allen NE; Appleby PN; Roddam AW; Rinaldi S; Egevad L; Gann PH; Rohrmann S; Linseisen J; Pischon T; Boeing H; Johnsen NF; Tjonneland A; Overvad K; Kiemeney L; Bueno-de-Mesquitalo HB; Bingham S; Khaw K-T; Tumino R; Sieri S; Vineis P; Palli D; Quiros JR; Ardanaz E; Chirlaque M-D; Larranaga N; Gonzalez C; Sanchez M-J; Trichopoulou A; Bikou C; Trichopoulos D; Stattin P; Jenab M; Ferrari P; Slimani N; Riboli E; Kaaks R

Article: AMERICAN JOURNAL OF CLINICAL NUTRITION. 2007;86(3):672-681

Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition study

Key TJ; Appleby PN; Allen NE; Travis RC; Roddam AW; Jenab M; Egevad L; Tionneland A; Johnsen NF; Overvad K; Linseisen J; Rohrmann S; Boeing H; Pischon T; Psaltopoulou T; Trichopoulou A; Trichopoulos D; Palli D; Vineis P; Tumino R; Berrino F; Kiemeney L; Bueno-de-Mesquita HB; Quiros JR; Gonzalez CA; Martinez C; Larranaga N; Chirlaque MD; Ardanaz E; Stattin P; Hallmans G; Khaw K-T; Bingham S; Slimani N; Ferrari P; Rinaldi S; Riboli E

Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2007;16(6):1121-1127

Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 concentrations and prostate cancer risk:: Results from the European prospective investigation into cancer and nutrition

Allen NE; Key TJ; Appleby PN; Travis RC; Roddam AW; Rinaldi S; Egevad L; Rohrmann S; Linseisen J; Pischon T; Boeing H; Johnsen NF; Tjonneland A; Gronbaek H; Overvad K; Kiemeney L; Bueno-de-Mesquita HB; Bingham S; Khaw KT; Tumino R; Berrino F; Mattiello A; Sacerdote C; Palli D; Quiros JR; Ardanaz E; Navarro C; Larranaga N; Gonzalez C; Sanchez M-J; Trichopoulou A; Travezea C; Trichopoulos D; Jenab M; Ferrari P; Riboli E; Kaaks R

Article: CANCER IMMUNOLOGY IMMUNOTHERAPY. 2007;56(5):677-687

Tumor specific phage particles promote tumor regression in a mouse melanoma model

Eriksson F; Culp WD; Massey R; Egevad L; Garland D; Persson MAA; Pisa P

Article: UROLOGY. 2007;69(4):778.e11-778.e13

Primary seminal vesicle carcinoma detected at transurethral resection of prostate

Egevad L; Ehrnstrom R; Hakansson U; Grabe M

Article: CELLULAR ONCOLOGY. 2007;29(1):32-40

Proteomics in prostate cancer research

Hellstrom M; Lexander H; Franzen B; Egevad L

Article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. 2007;41(4):302-307

Prevalence of prostate cancer at different levels of serum prostate-specific antigen (PSA) and different free:: Total PSA ratios in a consecutive series of men referred for prostate biopsies

Ryden L; Egevad L; Ekman P; Hellstrom M

Article: VIRCHOWS ARCHIV. 2006;449(6):622-627

The significance of modified Gleason grading of prostatic carcinoma in biopsy and radical prostatectomy specimens

Helpap B; Egevad L

Article: JOURNAL OF IMMUNOLOGY. 2006;177(10):7398-7405

CD4⁺CD25^high T cells are enriched in the tumor and peripheral blood of prostate cancer patients

Miller AM; Lundberg K; Ozenci V; Banham AH; Hellstrom M; Egevad L; Pisa P

Article: VIRCHOWS ARCHIV. 2006;449(3):297-301

Tissue shrinkage after fixation with formalin injection of prostatectomy specimens

Jonmarker S; Valdman A; Lindberg A; Hellstrom M; Egevad L

Article: PROTEOMICS. 2006;6(15):4370-4380

Correlation of protein expression, Gleason score and DNA ploidy in prostate cancer

Lexander H; Palmberg C; Hellman U; Auer G; Hellstrom M; Franzen B; Jornvall H; Egevad L

Article: PROTEOMICS. 2006;6(13):3918-3925

Evaluation of two sample preparation methods for prostate proteome analysis

Lexander H; Hellman U; Palmberg C; Auer G; Hellstrom M; Franzen B; Jornvall H; Egevad L

Article: JOURNAL OF PROTEOME RESEARCH. 2006;5(6):1332-1343

Proteomic analysis of tumor establishment and growth in the B16-F10 mouse melanoma model

Culp WD; Neal R; Massey R; Egevad L; Pisa P; Garland D

Article: INTERNATIONAL JOURNAL OF CANCER. 2006;118(10):2485-2489

Switch to full-length of XAF1 mRNA expression in prostate cancer cells by the DNA methylation inhibitor

Fang XL; Liu ZX; Fan YD; Zheng CY; Nilson S; Egevad L; Ekman P; Xu DW

Article: DIAGNOSTIC CYTOPATHOLOGY. 2006;34(5):317-322

Cytological features of prostatic intraepithelial neoplasia

Valdman A; Jonmarker S; Ekman P; Egevad L

Article: HUMAN PATHOLOGY. 2006;37(3):292-297

Current practice of diagnosis and reporting of prostate cancer on needle biopsy among genitourinary pathologists

Egevad L; Allsbrook WC; Epstein JI

Article: MODERN PATHOLOGY. 2006;19(2):180-185

Current practice of diagnosis and reporting of prostatic intraepithelial neoplasia and glandular atypia among genitourinary pathologists

Egevad L; Allsbrook WC; Epstein JI

Article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. 2006;40(6):465-471

Prediction of percent Gleason grade 4/5 by multiple core biopsies

Glaessgen A; Busch C; Norberg M; Haggman M; Nilsson B; Egevad L

Article: EUROPEAN UROLOGY. 2005;48(5):852-857

Ezrin expression in prostate cancer and benign prostatic tissue

Valdman A; Fang XL; Pang ST; Nilsson B; Ekman P; Egevad L

Article: CELLULAR ONCOLOGY. 2005;27(5):263-272

Proteomic analysis of protein expression in prostate cancer

Lexander H; Palmberg C; Auer G; Hellström M; Franzén B; Jörnvall H; Egevad L

Article: EUROPEAN UROLOGY. 2005;48(4):577-583

Tumor size, vascular density and proliferation as prognostic markers in GS 6 and GS 7 prostate tumors in patients with long follow-up and non-curative treatment

Josefsson A; Wikström P; Granfors T; Egevad L; Karlberg L; Stattin P; Bergh A

Article: PROSTATE. 2005;65(1):20-26

Presence and specificity of tumor associated lymphocytes from ascites fluid in prostate cancer

Ozenci V; Miller AM; Palmborg A; Egevad L; Jaremko GA; Kälkner KM; Pisa P

Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2005;29(9):1228-1242

The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma

Epstein JI; Allsbrook WC; Amin MB; Egevad LL; Bastacky S; Beltrán AL; Berner A; Billis A; Boccon-Gibod L; Cheng L; Civantos F; Cohen C; Cohen MB; Datta M; Davis C; Delahunt B; Delprado W; Eble JN; Foster CS; Furusato M; Gaudin PB; Grignon DJ; Humphrey PA; Iczkowski KA; Jones EC; Lucia S; McCue PA; Nazeer T; Oliva E; Pan CC; Pizov G; Reuter V; Samaratunga H; Sebo T; Sesterhenn I; Shevchuk M; Srigley JR; Suzigan S; Takahashi H; Tamboli P; Tan PH; Têtu B; Tickoo S; Tomaszewski JE; Troncoso P; Tsuzuki T; True LD; van der Kwast T; Wheeler TM; Wojno KJ; Young RH

Article: PROSTATE. 2005;62(4):394-399

Angiopoietin 2 expression is related to histological grade,vascular density, metastases, and outcome in prostate cancer

Lind AJ; Wikström P; Granfors T; Egevad L; Stattin P; Bergh A

Article: PROSTATE. 2005;62(3):217-223

Induction of PSA-specific CTLs and anti-tumor immunity by a genetic prostate cancer vaccine

Roos AK; Pavlenko M; Charo J; Egevad L; Pisa P

Article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. 2005;39(5):387-392

The significance of tumor heterogeneity for prediction of DNA ploidy of prostate cancer

Häggarth L; Auer G; Busch C; Norberg M; Häggman M; Egevad L

Article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. 2005;39(5):380-386

Prediction of the volume of large prostate cancers by multiple core biopsies

Häggarth L; Busch C; Norberg M; Häggman M; Norlén BJ; Egevad L

Article: HUMAN PATHOLOGY. 2005;36(1):5-9

Current practice of Gleason grading among genitourinary pathologists

Egevad L; Allsbrook WC; Epstein JI

Article: PROSTATE. 2004;60(4):367-371

Pim-I expression in prostatic intraepithelial neoplasia and human prostate cancer

Valdman A; Fang XL; Pang ST; Ekman P; Egevad L

Article: BRITISH JOURNAL OF CANCER. 2004;91(4):688-694

A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer

Pavlenko M; Roos AK; Lundqvist A; Palmborg A; Miller AM; Ozenci V; Bergman B; Egevad L; Hellström M; Kiessling R; Masucci G; Wersäll P; Nilsson S; Pisa P

Article: INTERNATIONAL JOURNAL OF CANCER. 2004;109(1):119-124

Fruits and vegetables and prostate cancer:: No association among 1,104 cases in a prospective study of 130,544 men in the European Prospective Investigation into Cancer and Nutrition (EPIC)

Key TJ; Allen N; Appleby P; Overvad K; Tjonneland A; Miller A; Boeing H; Karalis D; Psaltopoulou T; Berrino F; Palli D; Panico S; Tumino R; Vineis P; Bueno-de-Mesquita HB; Kiemeney L; Peeters PHM; Martinez C; Dorronsoro M; González CA; Chirlaque MD; Quiros JR; Ardanaz E; Berglund G; Egevad L; Hallmans G; Stattin P; Bingham S; Day N; Gann P; Kaaks R; Ferrari P; Riboli E

Article: UROLOGY. 2004;63(3):609-612

Expression of ezrin in prostatic intraepithelial neoplasia

Pang ST; Fang XL; Valdman A; Norstedt G; Pousette Å; Egevad L; Ekman P

Article: JOURNAL OF UROLOGY. 2004;171(2):664-667

Interobserver reproducibility of percent Gleason grade 4/5 in prostate biopsies

Glaessgen A; Hamberg H; Pihl CG; Sundelin B; Nilsson B; Egevad L

Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2004;101(3):811-816

Gene expression profiling identifies clinically relevant subtypes of prostate cancer

Lapointe J; Li C; Higgins JP; van de Rijn M; Bair E; Montgomery K; Ferrari M; Egevad L; Rayford W; Bergerheim U; Ekman P; DeMarzo AM; Tibshirani R; Botstein D; Brown PO; Brooks JD; Pollack JR

Article: KIDNEY INTERNATIONAL. 2003;64(5):1671-1674

VHL down-regulation and differential localization as mechanisms in tumorigenesis

Shiao YH; Forsti A; Egevad L; Anderson LM; Lindblad P; Hemminki K

Article: VIRCHOWS ARCHIV. 2003;445(1):17-21

Interobserver reproducibility of modified Gleason score in radical prostatectomy specimens

Glaessgen A; Hamberg H; Pihl CG; Sundelin B; Nilsson B; Egevad L

Article: DIAGNOSTIC CYTOPATHOLOGY. 2003;28(5):239-244

Cytology of the central zone of the prostate

Egevad L

Article: VIRCHOWS ARCHIV. 2003;442(4):329-335

Overexpression of IGBFB2 is a marker for malignant transformation in prostate epithelium

Richardsen E; Ukkonen T; Bjornsen T; Mortensen E; Egevad L; Busch C

Article: JOURNAL OF UROLOGY. 2002;168(5):2006-2010

Interobserver reproducibility of percent Gleason grade 4/5 in total prostatectomy specimens

Glaessgen A; Hamberg H; Pihl CG; Sundelin B; Nilsson B; Egevad L

Article: PROSTATE. 2002;53(3):192-199

Ultrastructure of the secretion of prostasomes from benign and malignant epithelial cells in the prostate

Sahlén GE; Egevad L; Ahlander A; Norlén BJ; Ronquist G; Nilsson BO

Article: JOURNAL OF UROLOGY. 2002;168(2):509-513

Percent Gleason grade 4/5 as prognostic factor in prostate cancer diagnosed at transurethral resection

Egevad L; Granfors T; Karlberg L; Bergh A; Stattin P

Article: BJU INTERNATIONAL. 2002;90(1):51-55

A new core-biopsy instrument with an end-cut technique provides prostate biopsies with increased tissue yield

Häggarth L; Ekman P; Egevad L

Article: PROSTATE. 2002;51(4):268-275

Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer

Wikström P; Lissbrandt IF; Stattin P; Egevad L; Bergh A

Article: CARCINOGENESIS. 2002;23(5):809-815

Molecular epidemiology of VHL gene mutations in renal cell carcinoma patients:: relation to dietary and other factors

Hemminki K; Jiang YW; Ma X; Yang K; Egevad L; Lindblad P

Article: BJU INTERNATIONAL. 2002;89(6):538-542

Prognostic value of the Gleason score in prostate cancer

Egevad L; Granfors T; Karlberg L; Bergh A; Stattin P

Article: BJU INTERNATIONAL. 2001;88(7):716-721

The value of multiple core biopsies for predicting the Gleason score of prostate cancer

Egevad L; Norlén BJ; Norberg M

Article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2001;31(10):880-886

Detection of cytochrome P450 mRNA transcripts in prostate samples by RT-PCR

Finnström N; Bjelfman C; Söderström TG; Smith G; Egevad L; Norlén BJ; Wolf CR; Rane A

Article: ONCOGENE. 2001;20(38):5393-5400

VHL gene alterations in renal cell carcinoma patients: novel hotspot or founder mutations and linkage disequilibrium

Ma X; Yang K; Lindblad P; Egevad L; Hemminki K

Article: UROLOGY. 2001;57(2):291-295

Reproducibility of Gleason grading of prostate cancer can be improved by the use of reference images

Egevad L

Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2001;86(2):855-858

Messenger ribonucleic acid levels of steroid 5α-reductase 2 in human prostate predict the enzyme activity

Söderström TG; Bjelfman C; Brekkan E; Ask B; Egevad L; Norlén BJ; Rane A

Article: CELLULAR AND MOLECULAR LIFE SCIENCES. 2001;58(2):307-311

Identification of proteins in human prostate tumor material by two-dimensional gel electrophoresis and mass spectrometry

Alaiya AA; Oppermann M; Langridge J; Roblick U; Egevad L; Brändstedt S; Hellström M; Linder S; Bergman T; Jörnvall H; Auer G

Article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. 2001;35(6):453-458

Relatively high risk of treatment failure after prostatectomy:: Tumour grade, histopathological stage and the preoperative serum PSA level are key prognosticators

Andersson J; Ekman P; Egevad L; Hellström M

Article: CELLULAR ONCOLOGY. 2001;23(3-4):159-165

Automatic registration and error detection of multiple slices using landmarks

Frimmel H; Egevad L; Busch C; Bengtsson E

Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2000;92(23):1910-1917

Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk:: a prospective study

Stattin P; Bylund A; Rinaldi S; Biessy C; Déchaud H; Stenman UH; Egevad L; Riboli E; Hallmans G; Kaaks R

Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2000;17(3):445-451

Tumor associated macrophages in human prostate cancer:: relation to clinicopathological variables and survival

Lissbrant IF; Stattin P; Wikström P; Damber JE; Egevad L; Bergh A

Article: CELLULAR ONCOLOGY. 2000;21(1):1-9

Polypeptide expression in prostate hyperplasia and prostate adenocarcinoma

Alaiya A; Roblick U; Egevad L; Carlsson A; Franzén B; Volz D; Huwendiek S; Linder S; Auer G

Article: UROLOGY. 1999;54(6):1028-1034

Modeling prostate cancer distributions

Frimmel H; Egevad L; Bengtsson E; Busch C

Article: UROLOGY. 1999;54(5):862-868

Biopsy protocol stability in a three-dimensional model of prostate cancer: Changes in cancer yield after adjustment of biopsy positions

Egevad L; Frimmel H; Mattson S; Bengtsson E; Busch C

Article: CANCER LETTERS. 1999;141(1-2):1-8

Novel somatic mutations in the VHL gene in Swedish archived sporadic renal cell carcinomas

Yang K; Lindblad P; Egevad L; Hemminki K

Article: PROSTATE. 1999;39(1):36-40

Distribution of prostasomes in neoplastic epithelial prostate cells

Nilsson BO; Egevad L; Jin MS; Ronquist G; Busch C

Article: UROLOGY. 1999;53(1):192-198

Three-dimensional computer reconstruction of prostate cancer from radical prostatectomy specimens: Evaluation of the model by core biopsy simulation

Egevad L; Frimmel H; Norberg M; Mattson S; Carlbom I; Bengtsson E; Busch C

Article: UROLOGY. 1998;52(4):653-658

Estimation of prostate cancer volume by multiple core biopsies before radical prostatectomy

Egevad L; Norberg M; Mattson S; Norlén BJ; Busch C

Article: UROLOGY. 1997;50(4):562-566

The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer

Norberg M; Egevad L; Holmberg L; Sparen P; Norlen BJ; Busch C

Article: PROSTATE. 1997;32(2):99-105

Expression of p21 and mutant p53 gene products in residual prostatic tumor cells after radical radiotherapy

Ljung G; Egevad L; Norberg M; Holmberg L; Nilsson S; Busch C

Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 1997;82(7):2210-2214

Differential gene expression of steroid 5 alpha-reductase 2 in core needle biopsies from malignant and benign prostatic tissue

Bjelfman C; Soderstrom TG; Brekkan E; Norlen BJ; Egevad L; Unge T; Andersson S; Rane A

Article: LAKARTIDNINGEN. 1997;94(26-27):2443

[More pathologists are needed in Sweden! Retirements may cause a real crisis].

Sundström C; Egevad L

Article: CELLULAR ONCOLOGY. 1997;15(3):145-156

A new method for segmentation of colour images applied to immunohistochemically stained cell nuclei

Ranefall P; Egevad L; Nordin B; Bengtsson E

Article: PROSTATE. 1996;29(5):303-310

Assessment of proliferation indicators in residual prostatic adenocarcinoma cells after radical external beam radiotherapy

Ljung G; Egevad L; Norberg M; delaTorre M; Holmberg L; Busch C; Nilsson S

Article: EUROPEAN RADIOLOGY. 1996;6(1):56-61

Multiple transrectal ultrasound-guided biopsies for the detection of prostate cancer and determination of tumor volume, grade, and seminal vesicle invasion

Norberg M; Holmberg L; Busch C; Haggman M; Egevad L; Magnusson A

Article: ACTA ONCOLOGICA. 1995;34(7):945-952

TRANSRECTAL ULTRASONICALLY-GUIDED CORE BIOPSIES IN THE ASSESSMENT OF LOCAL CURE OF PROSTATIC-CANCER AFTER RADICAL EXTERNAL-BEAM RADIOTHERAPY

LJUNG G; NORBERG M; HANSSON H; DELATORRE M; EGEVAD L; HOLMBERG L; BUSCH C; NILSSON S

About me

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI